Document:

Exhibit 10.11

 

Execution Version

 

FORWARD PURCHASE AGREEMENT

 

This Forward Purchase
Agreement (this “Agreement”) is entered into as of September 30, 2020, among Rice Acquisition Corp., a Delaware
corporation (the “Company”), Rice Acquisition Sponsor LLC, a Delaware limited liability company (the “Sponsor”),
Rice Acquisition Holdings LLC, a Delaware limited liability company (“Opco”), and Atlas Point Energy Infrastructure
Fund, LLC (the “Purchaser”).

 

WHEREAS, the Company
was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or
similar business combination with one or more businesses (a “Business Combination”);

 

WHEREAS, the Company
has confidentially submitted with the U.S. Securities and Exchange Commission (the “SEC”) a registration statement
on Form S-1 (the “Registration Statement”) for its initial public offering (“IPO”) of 20,000,000
units (or 23,000,000 units if the IPO over-allotment option (the “IPO Option”) is exercised in full) (the “Public
Units”), at an expected price of $10.00 per Public Unit (the “IPO Unit Price”), each Public Unit is
currently comprised of one share of the Company’s Class A common stock, par value $0.0001 per share (the “Class
A Shares,” and the Class A Shares included in the Public Units, the “Public Shares”), and one-third
of one redeemable warrant, where each whole redeemable warrant is exercisable to purchase one Class A Share at an exercise price
of $11.50 per share (the warrants included in the Public Units, the “Public Warrants”);

 

WHEREAS, the Company
may amend the Registration Statement to increase the size of the IPO and make other changes to the terms of the IPO;

 

WHEREAS, following
the closing of the IPO (the “IPO Closing”), the Company will seek to identify and consummate a Business Combination;

 

WHEREAS, in addition
to certain other interests in the Company and Opco, the Sponsor owns 5,750,000 Class B Units of Opco (the “Class B Units”)
that will convert into Class A Units of Opco (“Class A Units”) in connection with the Business Combination in
accordance with the Opco LLCA (as defined below), and a corresponding number of shares of the Company’s Class B common stock,
par value $0.0001 per share (the “Class B Shares”), which together comprise the “Founder Shares,”
and which will be decreased if the IPO Option is not exercised;

 

WHEREAS, the Founder
Shares will be exchangeable for Class A Shares after the time of the Business Combination pursuant to the Company’s certificate
of incorporation, as amended from time to time (the “Charter”) and Opco’s limited liability company agreement,
as amended as of the IPO Closing or otherwise from time to time (the “Opco LLCA”); and

 

WHEREAS, proceeds from
the IPO and the private placement of warrants to the Sponsor in an aggregate amount equal to approximately the gross proceeds from
the IPO will be deposited into a trust account for the benefit of the holders of the Public Shares and Class A Units (other than
the Company) (the “Trust Account”), as described in the Registration Statement.

 

NOW, THEREFORE, in
consideration of the premises, representations, warranties and the mutual covenants contained in this Agreement, and for other
good and valuable consideration, the receipt, sufficiency and adequacy of which are hereby acknowledged, the parties hereto agree
as follows:

 

1.
Commitment.

 

(a) Subject to the
terms and conditions hereof, the Purchaser hereby commits to purchase up to $75,000,000, and the Company agrees to issue and sell
to the Purchaser such amount of either, at the Company’s sole option, (i) forward purchase units at a price per unit equal
to the IPO Unit Price, consisting of Class A Shares (the “Forward Purchase Shares”) and warrants (the “Forward
Purchase Warrants”), with the Forward Purchase Shares having the same terms as the Public Shares offered to the public
in the IPO and, if the Public Warrants comprising the Public Units offered to the public in the IPO consist of one-half of one
redeemable warrant, the Forward Purchase Warrants comprising the Forward Purchase Units will consist of one-third of one redeemable
warrant, and if the Public Warrants comprising the Public Units offered to the public in the IPO consist of one-third of one redeemable
warrant, the Forward Purchase Warrants comprising the Forward Purchase Units will consist of one-fourth of one redeemable warrant
(such Forward Purchase Shares and Forward Purchase Warrants, collectively, the “Forward Purchase Units”) or
(ii) Forward Purchase Shares at a price of $9.67 per Forward Purchase Share (such Forward Purchase Shares valued at $9.67 per share,
or the Forward Purchase Units, as the case may be, the “Forward Purchase Securities”).

 

     

     

    

 

(b) If the Purchaser
consents to the Business Combination as specified in Section 4(c)(iv) below, the Purchaser shall, in connection with granting
such consent, specify the aggregate amount (up to $75,000,000) of the Forward Purchase Securities that the Purchaser shall purchase
at Closing (as defined below) (such specified amount is referred to herein as the “Purchase Price”). At least
10 business days prior to the Closing after the Company has received the Purchaser’s consent as described in Section 4(c)(iv)
below, the Company will provide written notice to the Purchaser, which may be given by email, specifying whether it has elected
to issue the Purchaser Forward Purchase Units or Forward Purchase Shares as provided in Section 1(a) hereof.

 

2.
At-Risk Capital; Forfeiture and Issuance of Founder Shares.

 

(a) In connection with
the IPO Closing, the Purchaser shall enter into a purchase agreement with the same terms as that entered into by the Sponsor (the
“Purchase Agreement”) pursuant to which it will agree to purchase 401,733 warrants (or 441,733 warrants if the
IPO Option is exercised in full) at a price of $1.50 per warrant ($602,600 in the aggregate, or $662,600 if the IPO Option is exercised
in full) in a private placement that will close simultaneously with the IPO Closing, and the Company and Opco will agree to issue
and sell to the Purchaser such number of warrants having the same terms as the warrants to be purchased by the Sponsor in connection
with the IPO Closing, as described in the Registration Statement (the “Private Placement Warrants”). Each Private
Placement Warrant will be exercisable to purchase for $11.50 one Class A Share or, in certain circumstances, one Class A Unit,
together with a corresponding Class B Share. The number of Private Placement Warrants purchased by the Purchaser pursuant to the
Purchase Agreement will reduce the number of warrants purchased by the Sponsor by an equivalent amount and will be adjusted from
the number set forth herein as necessary so that the Purchaser purchases a number of Private Placement Warrants equal to 10% of
the total warrants purchased by the Sponsor and the Purchaser in connection with the IPO Closing. The purchase price per Private
Placement Warrant will be the purchase price per Private Placement Warrant described in most recent version of the Registration
Statement at the time the Purchase Agreement is signed and is subject to change from the amount set forth above. The Purchaser’s
Private Placement Warrants will be subject to a 30 day lock up following Business Combination closing.

 

(b) On the IPO Closing,
the Sponsor shall forfeit, and Opco shall issue to the Purchaser for no additional consideration, a number of Class B Units (and
the Sponsor shall transfer to the Purchaser a corresponding number of Class B Shares) equal to an aggregate of 5% of the Founder
Shares (the Class B Units and Class B Shares so issued and transferred to Purchaser, together with any Class A Units into which
they are converted or Class A Shares for which they are exchanged, in each case, pursuant to the Opco LLCA, the “Purchaser
Shares”). All references herein to amounts of the Founder Shares, including references to percentages or numbers of the
Founder Shares, shall be to the amount of the Founder Shares immediately after the IPO Closing (excluding any Founder Shares subject
to forfeiture as a result of the failure of the underwriters to exercise their IPO Option). The Purchaser shall not be required
to forfeit any Purchaser Shares if the underwriters in the IPO do not exercise their IPO Option. If the Sponsor agrees to forfeit,
subject to forfeiture, or otherwise dispose of or encumber any of its Founder Shares in connection with a Business Combination
closing, the Purchaser agrees to similarly forfeit, subject to forfeiture, or otherwise dispose of or encumber a proportionate
number of its Purchaser Shares in connection with such Business Combination closing and execute any documents or other required
instruments in connection therewith.

 

(c) The Purchaser hereby
indicates an interest in purchasing up to 9.9% of the Public Units offered in the IPO for a maximum of $25,000,000. This indication
of interest is not a binding agreement or commitment to purchase and the Purchaser may elect not to purchase any Public Units in
the IPO. To the extent the Purchaser purchases Public Units in the IPO, the Purchaser agrees to forfeit all of the Purchaser Shares
received pursuant to Section 2(b) of this Agreement if it sells any Public Units purchased in the IPO prior to the Business
Combination closing.

 

    2

     

    

 

3.
Representations, Warranties and Agreements.

 

(a) Representations
and Warranties of the Purchaser. To induce the Company to issue the Forward Purchase Securities to the Purchaser, the Company
and Opco to issue the Private Placement Warrants and Purchaser Shares to the Purchaser and the Sponsor to forfeit and transfer
certain of the Founder Shares to the Purchaser, the Purchaser hereby represents and warrants to the Company, Opco and the Sponsor
and agrees with the Company, Opco and the Sponsor as follows:

 

(i)
Organization and Authority. The Purchaser is duly organized, validly existing and in good standing under the
laws of the jurisdiction of its formation and has all requisite power and authority to carry on its business as presently conducted
and as proposed to be conducted. The Purchaser has full power and authority to enter into this Agreement. This Agreement, when
executed and delivered by each of the parties hereto, will constitute the valid and legally binding obligation of the Purchaser,
enforceable against the Purchaser in accordance with its terms, except (A) as limited by applicable bankruptcy, insolvency, reorganization,
moratorium, fraudulent conveyance and any other laws of general application affecting enforcement of creditors’ rights generally,
(B) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies or
(C) to the extent the indemnification provisions contained in the Registration Rights (as defined below) may be limited by applicable
federal or state securities laws.

 

(ii)
No Conflicts. The execution, delivery and performance of this Agreement and the consummation by the Purchaser
of the transactions contemplated hereby do not violate, conflict with or constitute a default under (A) the formation and governing
documents of the Purchaser, (B) any agreement, indenture or instrument to which the Purchaser is a party, (C) any law, statute,
rule or regulation to which the Purchaser is subject, or (D) any agreement, order, judgment or decree to which the Purchaser is
subject.

 

(iii)
No Governmental Consents. No governmental, administrative or other third party consents or approvals are required,
necessary or appropriate on the part of the Purchaser in connection with the transactions contemplated by this Agreement.

 

(iv)
Adequacy of Financing. At the time of the IPO Closing and the Closing, as applicable, the Purchaser will have
available to it sufficient funds to satisfy its obligations under this Agreement.

 

(v)
Experience, Financial Capability and Suitability. The Purchaser is: (A) sophisticated in financial and tax matters
and is able to evaluate the risks and benefits of the investment in the Forward Purchase Securities, Private Placement Warrants
and the Purchaser Shares and (B) able to bear the economic and tax risk of its investment in the Forward Purchase Securities,
Private Placement Warrants and the Purchaser Shares for an indefinite period of time because the Forward Purchase Securities,
Private Placement Warrants and the Founder Shares have not been registered under the Securities Act of 1933, as amended (the “Securities
Act”) and therefore cannot be sold unless subsequently registered under the Securities Act or an exemption from such
registration is available. The Purchaser is capable of evaluating the merits and risks of its investment in the Company and has
the capacity to protect its own interests. The Purchaser must bear the economic and tax risk of this investment until the Forward
Purchase Securities, Private Placement Warrants and Purchaser Shares are sold pursuant to: (1) an effective registration statement
under the Securities Act or (2) an exemption from registration available with respect to such sale. The Purchaser is able to bear
the economic and tax risks of an investment in the Forward Purchase Securities, Private Placement Warrants and the Purchaser Shares
and to afford a complete loss of the Purchaser’s investment in the Forward Purchase Securities, Private Placement Warrants
and the Purchaser Shares.

 

(vi)
Access to Information; Independent Investigation. Prior to the execution of this Agreement, the Purchaser has
had the opportunity to ask questions of and receive answers from representatives of the Company concerning an investment in the
Company, as well as the finances, operations, business and prospects of the Company, and the opportunity to obtain additional
information to verify the accuracy of all information so obtained. In determining whether to make this investment, the Purchaser
has relied solely on the Purchaser’s own knowledge and understanding of the Company and its business based upon the Purchaser’s
own due diligence investigation and the information furnished pursuant to this paragraph. The Purchaser understands that no person
has been authorized to give any information or to make any representations which were not furnished pursuant to this Section 3
and the Purchaser has not relied on any other representations or information in making its investment decision, whether written
or oral, relating to the Company, its operations and/or its prospects.

 

    3

     

    

 

(vii)
Investment Purposes. The Purchaser is purchasing the Forward Purchase Securities, Private Placement Warrants
and acquiring the Purchaser Shares solely for investment purposes and not with a view towards the further distribution or dissemination
thereof. The Purchaser did not decide to enter into this Agreement as a result of any general solicitation or general advertising
within the meaning of Rule 502 under the Securities Act.

 

(viii)
Accredited Investor. The Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D promulgated
under the Securities Act.

 

(ix)
No General Solicitation. Neither the Purchaser, nor any of its officers, directors, employees, agents, stockholders
or partners has either directly or indirectly, including, through a broker or finder (A) engaged in any general solicitation or
(B) published any advertisement in connection with the offer and sale of the Forward Purchase Securities or the Private Placement
Warrants.

 

(x)
No Government Recommendation or Approval. The Purchaser understands that no federal or state agency has passed
upon or made any recommendation or endorsement of the offering of the Forward Purchase Securities, Private Placement Warrants
or the Purchaser Shares.

 

(xi)
No Public Market. The Purchaser understands that no public market now exists for the Forward Purchase Securities,
Private Placement Warrants or the Purchaser Shares, and that the Company has made no assurances that a public market will ever
exist for the Forward Purchase Securities, Private Placement Warrants or the Purchaser Shares.

 

(xii)
High Degree of Risk. The Purchaser understands that its agreement to purchase the Forward Purchase Securities
and Private Placement Warrants and to acquire the Purchaser Shares involves a high degree of risk which could cause the Purchaser
to lose all or part of its investment, and that it will be contractually obligated to vote any Class A Shares and Class B Shares
held by it in favor of the Business Combination as provided herein.

 

(xiii)
Restrictions on Transfer; Shell Company. The Purchaser understands the Forward Purchase Securities, Private
Placement Warrants and the Purchaser Shares are being offered in a transaction not involving a public offering within the meaning
of the Securities Act. The Purchaser understands the Forward Purchase Securities, Private Placement Warrants and the Purchaser
Shares will be “restricted securities” within the meaning of Rule 144(a)(3) under the Securities Act and the Purchaser
understands that any certificates representing the Forward Purchase Securities, Private Placement Warrants and the Purchaser Shares
will contain a legend in respect of such restrictions. If in the future the Purchaser decides to offer, resell, pledge or otherwise
transfer the Forward Purchase Securities, Private Placement Warrants or the Purchaser Shares, such securities may be offered,
resold, pledged or otherwise transferred only pursuant to: (A) registration under the Securities Act or (B) an available exemption
from registration. The Purchaser agrees that if any transfer of its Forward Purchase Securities, Private Placement Warrants or
Purchaser Shares or any interest therein is proposed to be made, as a condition precedent to any such transfer, the Purchaser
may be required to deliver to the Company an opinion of counsel satisfactory to the Company. Absent registration or an exemption,
the Purchaser agrees not to resell the Forward Purchase Securities, Private Placement Warrants or the Purchaser Shares. The Purchaser
further acknowledges that because the Company is a shell company, Rule 144 may not be available to the Purchaser for the resale
of the Forward Purchase Securities, Private Placement Warrants or the Purchaser Shares until one (1) year following the filing
of a Form 8-K announcing the consummation of the Business Combination.

 

(xiv)
Residence. The Purchaser’s principal place of business is the office or offices located at the address
of the Purchaser set forth on the signature page hereof.

 

(xv)
Affiliation of Certain FINRA Members. The Purchaser is neither a person associated nor affiliated with Barclays
Capital Inc. Upon request of the Company, the Purchaser shall confirm this representation with respect to any other member of
the Financial Industry Regulatory Authority (“FINRA”) that is participating in the IPO.

 

    4

     

    

 

(xvi)
No Other Representations and Warranties; Non-Reliance. Except for the specific representations and warranties
contained in this Section 3 and in any certificate or agreement delivered pursuant hereto, none of the Purchaser nor
any person acting on behalf of the Purchaser nor any of the Purchaser’s affiliates (the “Purchaser Parties”)
has made, makes or shall be deemed to make any other express or implied representation or warranty with respect to the Purchaser
and this offering, and the Purchaser Parties disclaim any such representation or warranty. Except for the specific representations
and warranties expressly made by the Company and the Sponsor in Section 3 of this Agreement and in any certificate
or agreement delivered pursuant hereto, the Purchaser Parties specifically disclaim that they are relying upon any other representations
or warranties that may have been made by the Company, Opco, any person on behalf of the Company or Opco or the Sponsor or any
of the Company’s other affiliates (collectively, the “Company Parties”).

 

(b) Representations
and Warranties of the Company and Opco. To induce the Purchaser to purchase the Forward Purchase Securities and the Private
Placement Warrants and to acquire the Purchaser Shares, the Company and Opco hereby represent and warrant to the Purchaser and
agree with the Purchaser as follows:

 

(i)
Organization and Corporate Power. The Company is a corporation duly incorporated and validly existing and in
good standing as a corporation under the laws of the State of Delaware and has all requisite corporate power and authority to
carry on its business as presently conducted and as proposed to be conducted. The Company has no subsidiaries. Opco is a limited
liability company duly formed and validly existing and in good standing as a limited liability company under the laws of the State
of Delaware and has all requisite limited liability company power and authority to carry on its business as presently conducted
and as proposed to be conducted.

 

(ii)
No Conflicts. The execution, delivery and performance of this Agreement and the consummation by the Company
of the transactions contemplated hereby do not violate, conflict with or constitute a default under (A) the organizational documents
of the Company or Opco, (B) any agreement, indenture or instrument to which the Company or Opco is a party, (C) any law, statute,
rule or regulation to which the Company or Opco is subject, or (D) any agreement, order, judgment or decree to which the Company
or Opco is subject.

 

(iii)
Title to Securities. Upon issuance in accordance with, and payment pursuant to, the terms hereof or the Purchase
Agreement, as applicable, the Forward Purchase Securities, the Private Placement Warrants, the securities issuable upon exercise
of the Private Placement Warrants and (assuming the Company issues Forward Purchase Units hereunder) the securities issuable upon
exercise of the Forward Purchase Warrants, when issued in accordance with the terms of the Forward Purchase Warrants, the Private
Placement Warrants and this Agreement or the Purchase Agreement, as applicable, will be duly and validly issued, fully paid and
non-assessable, as applicable. Upon issuance in accordance with, and payment pursuant to, the terms hereof the Purchaser will
have or receive good title to the Forward Purchase Securities and Private Placement Warrants, free and clear of all liens, claims
and encumbrances of any kind, other than (A) transfer restrictions under federal and state securities laws, and (B) liens, claims
or encumbrances imposed due to the actions of the Purchaser.

 

(iv)
No Adverse Actions. There are no actions, suits, investigations or proceedings pending, threatened against or
affecting the Company or Opco which (A) seek to restrain, enjoin, prevent the consummation of or otherwise affect the transactions
contemplated by this Agreement or (B) question the validity or legality of any transactions or seeks to recover damages or to
obtain other relief in connection with any transactions.

 

(v)
Authorization. All corporate or limited liability company action, as applicable, on the part of the Company,
Opco, and their respective officers, directors and stockholders necessary for the authorization, execution and delivery of this
Agreement, the performance of all obligations of the Company and Opco required pursuant hereto and the authorization and issuance
(or reservation for issuance) of the Forward Purchase Securities, the Private Placement Warrants and the securities issuable upon
exercise of the Private Placement Warrants and (assuming the Company issues Forward Purchase Units hereunder) the securities issuable
upon exercise of the Forward Purchase Warrants, has been taken or will be taken prior to the Closing. This Agreement, when executed
and delivered by each of the parties hereto, will constitute the valid and legally binding obligation of the Company and Opco,
enforceable against the Company and Opco in accordance with its terms, except (A) as limited by applicable bankruptcy, insolvency,
reorganization, moratorium, fraudulent conveyance and any other laws of general application affecting enforcement of creditors’
rights generally, (B) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable
remedies or (C) to the extent the indemnification provisions contained in the Registration Rights (as defined below) may be limited
by applicable federal or state securities laws.

 

    5

     

    

 

(vi)
Capitalization. The authorized capital stock of the Company on the date hereof, consists of 200,000,000 Class
A Shares, 2,500 of which are issued and outstanding, 20,000,000 Class B Shares, 5,750,100 of which are issued and outstanding
as of the date hereof (including up to 750,000 shares subject to forfeiture in the event that the underwriters’ IPO Option
is not exercised in full) and 1,000,000 preferred shares, none of which are issued and outstanding. The outstanding limited liability
company interests of Opco on the date hereof, consists of 2,600 Class A Units and 5,750,000 Class B Units (including up to 750,000
Class B Units subject to forfeiture in the event that the underwriters’ IPO Option is not exercised in full). On the date
hereof, there are no outstanding rights, options, warrants, preemptive rights, rights of first refusal or similar rights for the
purchase or acquisition from the Company or Opco of any securities of the Company or Opco, other than the conversion and exchange
rights of the Class B Units and Class A Units, respectively, pursuant to the Opco LLCA.

 

(vii)
No Governmental Consents. Assuming the accuracy of the representations and warranties made by the Purchaser
in this Agreement, no governmental, administrative or other third party consents or approvals are required, necessary or appropriate
on the part of the Company in connection with the transactions contemplated by this Agreement, other than such state Blue Sky,
FINRA and New York Stock Exchange consents and approvals as may be required.

 

(viii)
No General Solicitation. No form of general solicitation or general advertising within the meaning of Regulation
D of the Securities Act (including, but not limited to, advertisements, articles, notices or other communications published in
any newspaper, magazine or similar medium or broadcast over television or radio, or any seminar or meeting whose attendees have
been invited by any general solicitation or general advertising) was used by the Company, Opco or any of its representatives in
connection with the offer and sale of the Forward Purchase Securities and the Private Placement Warrants.

 

(ix)
No Brokers. No broker, finder or similar intermediary has acted for or on behalf of the Company, Opco or any
of their respective affiliates in connection with this Agreement or the transactions contemplated hereby and no broker, finder,
agent or similar intermediary is entitled to any broker’s, finder’s or similar fee or other commission in connection
therewith.

 

(x)
No Other Representations and Warranties; Non-Reliance. Except for the specific representations and warranties
contained in Sections 3(b) and (c) and in any certificate or agreement delivered pursuant hereto, none of the Company
Parties has made, makes or shall be deemed to make any other express or implied representation or warranty with respect to the
Company, Opco, this offering, the proposed IPO or a potential Business Combination, and the Company Parties disclaim any such
representation or warranty. Except for the specific representations and warranties expressly made by the Purchaser in Section
3(a) and in any certificate or agreement delivered pursuant hereto, the Company Parties specifically disclaim that they are
relying upon any other representations or warranties that may have been made by the Purchaser Parties.

 

(c) Representations
and Warranties of the Sponsor. To induce the Purchaser to purchase the Forward Purchase Securities, Private Placement Warrants
and to acquire the Purchaser Shares, the Sponsor hereby represents and warrants to the Purchaser and agrees with the Purchaser
as follows:

 

(i)
Organization and Corporate Power. The Company is a limited liability company duly formed and validly existing
and in good standing as a limited liability company under the laws of the State of Delaware and has all requisite limited liability
company power and authority to carry on its business as presently conducted and as proposed to be conducted.

 

(ii)
No Conflicts. The execution, delivery and performance of this Agreement and the consummation by the Sponsor
of the transactions contemplated hereby do not violate, conflict with or constitute a default under (A) the certificate of formation
or limited liability company agreement of the Sponsor, (B) any agreement, indenture or instrument to which the Sponsor is a party,
(C) any law, statute, rule or regulation to which the Sponsor is subject, or (D) any agreement, order, judgment or decree to which
the Sponsor is subject.

 

    6

     

    

 

(iii)
Ownership. The Sponsor is the record and beneficial owner of, and has good and marketable title to, the Founder
Shares, free and clear of all liens, security interests, charges, claims, restrictions and other encumbrances, subject to securities
laws restrictions. Founder has not granted to any person or entity any options or other rights to buy the Founder Shares. No other
person or entity has any interest in the Founder Shares of any nature. The forfeiture and transfer of the Founder Shares and issuance
of Purchaser Shares to the Purchaser pursuant to this Agreement will not give any person a legal right or cause of action against
the Purchaser Shares or the Purchaser.

 

(iv)
No Other Representations and Warranties; Non-Reliance. Except for the specific representations and warranties
contained in Sections 3(b) and (c) and in any certificate or agreement delivered pursuant hereto, none of the Company
Parties has made, makes or shall be deemed to make any other express or implied representation or warranty with respect to the
Company, this offering, the proposed IPO or a potential Business Combination, and the Company Parties disclaim any such representation
or warranty.

 

4.
Settlement Date and Delivery.

 

(a) Closing of Purchase
of Securities. The consummation and settlement of the purchase and sale of the Forward Purchase Securities hereunder (the “Closing”)
shall be held at the same date and immediately prior to the Business Combination closing (the date of the Closing being referred
to as the “Closing Date”). At the Closing, the Company will issue to the Purchaser the Forward Purchase Securities,
each registered in the name of the Purchaser, against delivery of the Purchase Price in cash via wire transfer to an account specified
in writing by the Company no later than five business days prior to the Closing.

 

(b) Conditions to
Closing of the Company. The obligation of the Company to sell the Forward Purchase Securities at the Closing under this Agreement
shall be subject to the fulfillment, at or prior to the Closing of each of the following conditions, any of which, to the extent
permitted by applicable laws, may be waived by the Company:

 

(i)
Representations and Warranties Correct. The representations and warranties made by the Purchaser in Section
3(a) hereof shall be true and correct in all material respects when made and shall be true and correct in all material respects
on and as of the Closing Date and the IPO Closing, as the case may be, (unless they specifically speak as of another date in which
case they shall be true and correct in all material respects as of such date) with the same force and effect as if they had been
made on and as of said date.

 

(ii)
Covenants. All covenants, agreements and conditions contained in this Agreement to be performed by the Purchaser
on or prior to the Closing Date shall have been performed or complied with in all material respects.

 

(iii)
Business Combination Closing. The Business Combination shall be consummated substantially concurrently with
the purchase of the Forward Purchase Securities.

 

(iv)
Performance of Covenants. The Purchaser shall have performed, satisfied and complied in all material respects
with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Purchaser
at or prior to the Closing.

 

(v)
No Injunction. No order, writ, judgment, injunction, decree, determination, or award shall have been entered
by or with any governmental, regulatory, or administrative authority or any court, tribunal, or judicial, or arbitral body, and
no other legal restraint or prohibition shall be in effect, preventing the purchase by the Purchaser of the Forward Purchase Securities.

 

    7

     

    

 

(c) Conditions to
Closing of the Purchaser. The obligation of the Purchaser to purchase the Forward Purchase Securities at the Closing under
this Agreement shall be subject to the fulfillment, at or prior to the Closing of each of the following conditions, any of which,
to the extent permitted by applicable laws, may be waived by the Purchaser:

 

(i)
Representations and Warranties Correct. The representations and warranties made by the Company, Opco and the
Sponsor in Sections 3(b) and (c) hereof shall be true and correct in all material respects when made and shall be
true and correct in all material respects on and as of the Closing Date and the IPO Closing, as the case may be (unless they specifically
speak as of another date in which case they shall be true and correct in all material respects as of such date), with the same
force and effect as if they had been made on and as of said date.

 

(ii)
Covenants. All covenants, agreements and conditions contained in this Agreement to be performed by the Company,
Opco and the Sponsor on or prior to the Closing Date shall have been performed or complied with in all material respects.

 

(iii)
Blue Sky. The Company shall have obtained all necessary Blue Sky law permits and qualifications, or secured
an exemption therefrom, required by any state for the offer and sale of the Forward Purchase Securities.

 

(iv)
Purchaser Consent. The Purchaser shall have given irrevocable written consent (in its capacity as a party to
this Agreement and not as a stockholder), which may be given by e-mail, to the Company confirming its commitment to purchase the
Forward Purchase Securities (which it may withhold at its sole discretion) and the amount of the Purchase Price, which consent
shall be withheld or granted no later than five (5) days after receipt of notification that the board of directors of the Company
(the “Board”) will meet to consider entering into a definitive acquisition agreement for the Business Combination.
Prior to entering into any definitive agreement setting forth the terms and conditions of, and binding the Company (subject to
any conditions and qualifications set forth in such agreement) to effect, a Business Combination, any agreement relating to the
forfeiture of Founder Shares or Purchaser Shares or any other material agreement to be executed in connection with such definitive
agreement (collectively, a “Business Combination Agreement”), the Company shall give written notice to the
Purchaser stating its bona fide intention to enter into a Business Combination Agreement. The Company will provide the Purchaser
with applicable materials and information in order for the Purchaser to evaluate whether to provide a consent to the proposed
Business Combination, including the material terms of the transaction and any other information reasonably requested by the Purchaser
with respect to the proposed Business Combination, such materials and information to be provided subject to the terms of a non-disclosure
agreement to be entered between the Company and the Purchaser in accordance with applicable law (including Regulation FD under
the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) and the Company’s contractual obligations;
provided, that the Company shall have the right to refuse to provide any such materials or information if, in the opinion of the
Company, acting reasonably and in good faith having received the advice of counsel, the provision of such materials or information
could violate applicable laws or regulations or result in any waiver of legal privilege of the Company; and provided, further,
that if the target entity’s equity or debt securities are traded on a securities exchange or over-the-counter market, prior
to providing such materials and information, the Company will first provide only the name of the potential target to a legal or
compliance person designated by the Purchaser in writing as authorized to receive such information (such person, the “Designated
Person”) so that the Purchaser can determine if it has an internal restriction on the receipt of such materials or information.
In addition, at the election of the Purchaser, the Company and the Sponsor will use commercially reasonable efforts to allow the
Purchaser to attend or participate in due diligence sessions with and/or meetings with management of the target entity in a potential
Business Combination, subject, in each case, to the Purchaser entering into a non-disclosure agreement with the applicable target
entity in a potential Business Combination and complying with other applicable rules and procedures established by such target
entity.

 

(v)
Business Combination Closing. The Business Combination shall be consummated substantially concurrently with
the purchase of the Forward Purchase Securities.

 

(vi)
No Injunction. No order, writ, judgment, injunction, decree, determination, or award shall have been entered
by or with any governmental, regulatory, or administrative authority or any court, tribunal, or judicial, or arbitral body, and
no other legal restraint or prohibition shall be in effect, preventing the purchase by the Purchaser of the Forward Purchase Securities.

 

5.
Terms of the Forward Purchase Securities. The Forward Purchase Securities are being offered and sold pursuant
to an exemption from the registration requirements of the Securities Act and will be “restricted securities” within
the meaning of Rule 144(a)(3) under the Securities Act. If in the future the Purchaser decides to offer, resell, pledge or otherwise
transfer the Forward Purchase Securities, such securities may be offered, resold, pledged or otherwise transferred only pursuant
to: (a) registration under the Securities Act or (b) an available exemption from registration under the Securities Act.

 

    8

     

    

 

6.
Restrictions on Transfer.

 

(a) Securities Law
Restrictions. The Purchaser hereby agrees not to sell, transfer, pledge, hypothecate or otherwise dispose of all or any part
of the Forward Purchase Securities, Private Placement Warrants or the Purchaser Shares unless, prior thereto (i) a registration
statement on the appropriate form under the Securities Act and applicable state securities laws with respect to the Forward Purchase
Securities, Private Placement Warrants, the Class A Shares underlying the Forward Purchase Warrants and the Private Placement Warrants
and the Purchaser Shares proposed to be transferred shall then be effective or (ii) the Company has received an opinion of counsel
for the Company that such registration is not required because such transaction is exempt from registration under the Securities
Act and the rules promulgated by the SEC thereunder and under all applicable state securities laws. All certificates representing
the Forward Purchase Securities, Private Placement Warrants and the Purchaser Shares shall have endorsed thereon a legend substantially
as follows:

 

“THE SECURITIES REPRESENTED
HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS AND NEITHER THE SECURITIES
NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER SUCH ACT OR SUCH LAWS OR AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT AND SUCH LAWS WHICH, IN THE OPINION OF COUNSEL,
IS AVAILABLE.”

 

(b) Founder Share
Lock-Up. The Purchaser Shares held by the Purchaser will be subject to the same transfer restrictions as the Founder Shares
held by the Sponsor and the Purchaser agrees to enter into a letter agreement containing customary terms for transactions of the
type contemplated by this Agreement, and in a form substantially similar to that entered into by the Sponsor, prior to or on the
IPO Closing.

 

(c) Registration
Rights. The Purchaser will be entitled to the same registration rights as the Sponsor and agrees to enter into a registration
rights agreement containing customary terms for transactions of the type contemplated by this Agreement, and in a form substantially
similar to that entered into by the Sponsor, to be signed prior to or on the IPO Closing.

 

7.
Board Observer. Until such time as the Registration Statement shall be declared effective, the Company
agrees to take such action so as to ensure that as of the effective time of such Registration Statement and at all times thereafter
until consummation of the Business Combination the Purchaser shall have the right to designate an observer to the Board; provided,
however, that such observer shall not have the right to vote on any matter that shall come before the Board or otherwise have any
powers of a member of the Board; provided, further, that the Purchaser shall not have the right to designate an observer to the
Board at any time that the Purchaser or any of the Purchaser’s affiliates has the right to designate a director or observer
to the board of directors of a special purchase acquisition company that is focused on an industry similar to that which the Company
is focused.

 

8.
Other Agreements.

 

(a) Further Assurances.
Each of the Company and the Purchaser agrees to execute such further instruments and to take such further action as may reasonably
be necessary to carry out the intent of this Agreement, including execution of a joinder to the Opco LLCA and delivery of any tax
certificates or forms reasonably requested by Opco or the Company (including an IRS Form W-9)..

 

(b) Notices.
All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively
given upon the earlier of actual receipt, or (i) personal delivery to the party to be notified, (ii) when sent, if sent by electronic
mail or facsimile (if any) during normal business hours of the recipient, and if not sent during normal business hours, then on
the recipient’s next Business Day, (iii) five (5) Business Days after having been sent by registered or certified mail, return
receipt requested, postage prepaid, or (iv) one (1) Business Day after deposit with a nationally recognized overnight courier,
freight prepaid, specifying next Business Day delivery, with written verification of receipt. All communications sent to the Company
shall be sent to: Rice Acquisition Corp., 102 East Main Street, Second Story, Carnegie, Pennsylvania 15106, Attention: Daniel Joseph
Rice, IV, with a copy to the Company’s counsel at Vinson & Elkins L.L.P., 1001 Fannin Street, Suite 2500, Houston, Texas
77002, Attention: David O. Oelman, E. Ramey Layne and Sarah K. Morgan.

 

    9

     

    

 

(c) Voting.
The Purchaser hereby agrees that if the Company seeks stockholder approval of a proposed Business Combination, then in connection
with such proposed Business Combination, the Purchaser shall vote any Class B Shares and Class A Shares owned by it in favor of
any proposed Business Combination.

 

(d) No Short Sales.
The Purchaser hereby agrees that neither it, nor any person or entity acting on its behalf or pursuant to any understanding with
it, will engage in any Short Sales with respect to securities of the Company prior to the Business Combination closing. For purposes
of this Section 8(d), “Short Sales” shall include, without limitation, all “short sales”
as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act, and all types of direct and indirect stock pledges
(other than pledges in the ordinary course of business as part of prime brokerage arrangements), forward sale contracts, options,
puts, calls, swaps and similar arrangements (including on a total return basis), and sales and other transactions through non-U.S.
broker dealers or foreign regulated brokers.

 

(e) Entire Agreement.
This Agreement, together with any documents, instruments and writing that are delivered pursuant hereto or referenced herein, constitute
the entire agreement and understanding of the parties hereto in respect of its subject matter and supersedes all prior understandings,
agreements or representations by or among the parties hereto, written or oral, to the extent they relate in any way to the subject
matter hereof or the transactions contemplated hereby.

 

(f) Modifications
and Amendments. The terms and provisions of this Agreement may be modified or amended only by written agreement executed by
all parties hereto.

 

(g) Waivers and
Consents. The terms and provisions of this Agreement may be waived, or consent for the departure therefrom granted, only by
written document executed by the party entitled to the benefits of such terms or provisions. No such waiver or consent shall be
deemed to be or shall constitute a waiver or consent with respect to any other terms or provisions of this Agreement, whether or
not similar. Each such waiver or consent shall be effective only in the specific instance and for the purpose for which it was
given, and shall not constitute a continuing waiver or consent.

 

(h) Assignment.
The rights and obligations under this Agreement may not be assigned by any of the parties hereto without the prior written consent
of the other parties; provided that the Purchaser may assign its rights and obligations to an affiliate without the prior consent
of the other parties; provided further that, to the extent such assignment relates to Purchaser’s rights to acquire any Class
A Units or Class B Units, such an assignment of such units would be permitted pursuant to the Opco LLCA.

 

(i) Benefit.
All statements, representations, warranties, covenants and agreements in this Agreement shall be binding on the parties hereto
and shall inure to the benefit of the respective successors and permitted assigns of each party hereto. Nothing in this Agreement
shall be construed to create any rights or obligations except among the parties hereto, and no person or entity shall be regarded
as a third-party beneficiary of this Agreement.

 

(j) Governing Law.
This Agreement and the rights and obligations of the parties hereunder shall be construed in accordance with and governed by the
laws of Delaware applicable to contracts wholly performed within the borders of such state, without giving effect to the conflict
of law principles thereof.

 

(k) Jurisdiction.
The parties (i) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of Delaware for the purpose
of any suit, action or other proceeding arising out of or based upon this Agreement, (ii) agree not to commence any suit, action
or other proceeding arising out of or based upon this Agreement except in state courts of Delaware and (iii) hereby waive, and
agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is
not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or
execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding
is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.

 

    10

     

    

 

(l) Severability.
In the event that any court of competent jurisdiction shall determine that any provision, or any portion thereof, contained in
this Agreement shall be unreasonable or unenforceable in any respect, then such provision shall be deemed limited to the extent
that such court deems it reasonable and enforceable, and as so limited shall remain in full force and effect. In the event that
such court shall deem any such provision, or portion thereof, wholly unenforceable, the remaining provisions of this Agreement
shall nevertheless remain in full force and effect.

 

(m) No Waiver of
Rights, Powers and Remedies. No failure or delay by a party hereto in exercising any right, power or remedy under this Agreement,
and no course of dealing between the parties hereto, shall operate as a waiver of any such right, power or remedy of such party.
No single or partial exercise of any right, power or remedy under this Agreement by a party hereto, nor any abandonment or discontinuance
of steps to enforce any such right, power or remedy, shall preclude such party from any other or further exercise thereof or the
exercise of any other right, power or remedy hereunder. The election of any remedy by a party hereto shall not constitute a waiver
of the right of such party to pursue other available remedies. No notice to or demand on a party not expressly required under this
Agreement shall entitle the party receiving such notice or demand to any other or further notice or demand in similar or other
circumstances or constitute a waiver of the rights of the party giving such notice or demand to any other or further action in
any circumstances without such notice or demand.

 

(n) Survival of
Representations and Warranties. All representations and warranties made by the parties hereto in this Agreement or in any other
agreement, certificate or instrument provided for or contemplated hereby, shall survive the execution and delivery hereof and any
investigations made by or on behalf of the parties.

 

(o) Headings and
Captions. The headings and captions of the various subdivisions of this Agreement are for convenience of reference only and
shall in no way modify or affect the meaning or construction of any of the terms or provisions hereof.

 

(p) Counterparts.
This Agreement may be executed in one or more counterparts, all of which when taken together shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being
understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or any other form of electronic delivery, such signature shall create a valid and binding obligation of the party executing (or
on whose behalf such signature is executed) with the same force and effect as if such signature page were an original thereof.

 

(q) Construction.
The words “include,” “includes,” and “including” will be deemed to be followed by “without
limitation.” Pronouns in masculine, feminine, and neuter genders will be construed to include any other gender, and words
in the singular form will be construed to include the plural and vice versa, unless the context otherwise requires. The words “this
Agreement,” “herein,” “hereof,” “hereby,” “hereunder,” and words of similar
import refer to this Agreement as a whole and not to any particular subdivision unless expressly so limited. The parties hereto
intend that each representation, warranty, and covenant contained herein will have independent significance. If any party hereto
has breached any representation, warranty, or covenant contained herein in any respect, the fact that there exists another representation,
warranty or covenant relating to the same subject matter (regardless of the relative levels of specificity) which such party hereto
has not breached will not detract from or mitigate the fact that such party hereto is in breach of the first representation, warranty,
or covenant.

 

(r) Mutual Drafting.
This Agreement is the joint product of the Purchaser and the Company and each provision hereof has been subject to the mutual consultation,
negotiation and agreement of such parties and shall not be construed for or against any party hereto.

 

9.
Indemnification. Each party shall indemnify the others against any loss, cost or damages (including reasonable
attorney’s fees and expenses) incurred as a result of such party’s breach of any representation, warranty, covenant
or agreement in this Agreement.

 

    11

     

    

 

10.
Termination. This Agreement may be terminated at any time prior to the Closing:

 

(a) by mutual written
consent of the Company and the Purchaser;

 

(b) automatically:

 

(i)
if the IPO is not consummated on or prior to March 30, 2021;

 

(ii)
if the Business Combination is not consummated within 24 months from the IPO Closing, including any extensions beyond
such term effected pursuant to the terms of the Charter; or

 

(iii)
if the Purchaser or the Company becomes subject to any voluntary or involuntary petition under the United States federal
bankruptcy laws or any state insolvency law, in each case which is not withdrawn within sixty (60) days after being filed, or
a receiver, fiscal agent or similar officer is appointed by a court for business or property of the Purchaser or the Company,
in each case which is not removed, withdrawn or terminated within sixty (60) days after such appointment.

 

In the event of any
termination of this Agreement pursuant to this Section 10, the Purchase Price (and interest thereon, if any), if previously
paid, and all Purchaser’s funds paid in connection herewith shall be promptly returned to the Purchaser, and thereafter this
Agreement shall forthwith become null and void and have no effect, without any liability on the part of the Purchaser or the Company
and their respective directors, officers, employees, partners, managers, members, or stockholders and all rights and obligations
of each party shall cease; provided, however, that nothing contained in this Section 10 shall relieve either party
from liabilities or damages arising out of any fraud or willful breach by such party of any of its representations, warranties,
covenants or agreements contained in this Agreement.

 

11.
Disclosure. The Purchaser hereby acknowledges that (a) the terms of this Agreement will be disclosed in
the Registration Statement, (b) this Agreement will be filed with the SEC as an exhibit to the Registration Statement and (c) the
Company will disclose the terms of this Agreement to potential IPO investors and to potential Business Combination targets.

 

12.
Waiver of Claims Against Trust. The Purchaser hereby acknowledges that it is aware that the Company will
cause Opco to establish a Trust Account for the benefit of the Company’s public stockholders and the holders of Class A Units
(other than the Company) upon the IPO Closing. The Purchaser, for itself and its affiliates, hereby agrees that it has no right,
title, interest or claim of any kind in or to any monies held in the Trust Account, or any other asset of the Company or Opco as
a result of any liquidation of the Company or Opco, except for redemption and liquidation rights, if any, the Purchaser may have
in respect of any Public Shares or Class Units of Opco held by the Purchaser. The Purchaser hereby agrees that it shall have no
right of set-off or any right, title, interest or claim of any kind (“Claim”) to, or to any monies in, the Trust
Account, and hereby irrevocably waives any Claim to, or to any monies in, the Trust Account that it may have now or in the future,
except for redemption and liquidation rights, if any, the Purchaser may have in respect of any Public Shares or Class A Units of
Opco held by the Purchaser. In the event the Purchaser has any Claim against the Company under this Agreement, the Purchaser shall
pursue such Claim solely against the Company and its assets outside the Trust Account and not against the property or any monies
in the Trust Account, except for redemption and liquidation rights, if any, the Purchaser may have in respect of any Public Shares
or Class A Units of Opco held by the Purchaser.

 

[Signature Page Follows]

 

    12

     

    

 

IN WITNESS WHEREOF,
the undersigned have executed this Agreement to be effective as of the date first set forth above.

 

	 	PURCHASER:
	 	 
	 	ATLAS POINT ENERGY INFRASTRUCTURE FUND, LLC
	 	 	 
	 	By:	/s/ Adam Karpf
	 	 	Name: Adam Karpf
	 	 	Title: Managing Director and Portfolio Manager
	 	 	 
	 	Address for Notices:
	 	 
	 	E-mail: Adam.Karpf@cibc.com
	 	 	 
	 	COMPANY:
	 	 
	 	RICE ACQUISITION CORP.
	 	 	 
	 	By:	/s/ Daniel Joseph Rice, IV
	 	 	Name: Daniel Joseph Rice, IV
	 	 	Title: Chief Executive Officer
	 	 	 
	 	SPONSOR:
	 	 
	 	RICE ACQUISITION SPONSOR LLC
	 	 	 
	 	By:	/s/ Daniel Joseph Rice, IV
	 	 	Name: Daniel Joseph Rice, IV
	 	 	Title: Chief Executive Officer
	 	 	 
	 	OPCO:
	 	 
	 	RICE ACQUISITION HOLDINGS LLC
	 	 	 
	 	By:	/s/ Daniel Joseph Rice, IV
	 	 	Name: Daniel Joseph Rice, IV
	 	 	Title: Chief Executive OfficerExhibit 4.1

 

WARRANT AGREEMENT

 

THIS WARRANT AGREEMENT (this “Agreement”),
dated as of September 30, 2020, is by and between IG Acquisition Corp., a Delaware corporation (the “Company”),
and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, the “Warrant Agent”,
and also referred to herein as the “Transfer Agent”).

 

WHEREAS, the Company is engaged in an initial
public offering (the “Offering”) of units of the Company’s equity securities, each such unit comprised
of one share of Class A common stock of the Company, par value $0.0001 per share (“Common Stock”), and
one-half of one redeemable Public Warrant (as defined below) (the “Units”) and, in connection therewith,
has determined to issue and deliver up to 15,000,000 warrants (or up to 17,250,000 warrants if the Over-allotment Option (defined
below) is exercised in full) to public investors in the Offering (the “Public Warrants”);

 

WHEREAS, the Company has entered into that
certain Private Placement Warrants Purchase Agreement (“Private Placement Warrants Purchase Agreement”)
with IG Sponsor LLC, a Delaware limited liability company (the “Sponsor”), pursuant to which the Sponsor
agreed to purchase an aggregate of 8,000,000 warrants (or 8,900,000 in the event that the Over-allotment Option is exercised in
full) simultaneously with the closing of the Offering bearing the legend set forth in Exhibit B hereto (the “Private Placement Warrants”)
at a purchase price of $1.00 per Private Placement Warrant;

 

WHEREAS, in order to finance the Company’s
transaction costs in connection with an intended initial Business Combination (defined in Section 3.2), the Sponsor, an
affiliate of the Sponsor, the Company’s officers and directors and other third parties may, but are not obligated to, loan
to the Company funds as the Company may require, of which up to $1,500,000 of such loans may be convertible into up to an additional
1,500,000 warrants at a price of $1.00 per warrant (the “Working Capital Warrants”);

 

WHEREAS, the Company has filed with the
Securities and Exchange Commission (the “Commission”) a registration statement on Form S-1, File No.
333- 248666 (the “Registration Statement”) and prospectus (the “Prospectus”),
for the registration, under the Securities Act of 1933, as amended (the “Securities Act”), of the
Units, the Public Warrants and the Common Stock included in the Units;

 

WHEREAS, following consummation of the Offering,
the Company may issue additional warrants (the “Post IPO Warrants,” and together with the Private Placement
Warrants, the Working Capital Warrants and the Public Warrants, the “Warrants”) in connection with, or
following the consummation by the Company of, a Business Combination;

 

WHEREAS, each whole Warrant entitles the
holder thereof to purchase one share of Common Stock for $11.50 per whole share, subject to adjustment as described herein. Only
whole Warrants are exercisable. A holder of the Public Warrants will not be able to exercise any fraction of a Warrant;

 

WHEREAS, the Company desires the Warrant
Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with the issuance, registration,
transfer, exchange, redemption and exercise of the Warrants;

 

WHEREAS, the Company desires to provide
for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised, and the respective rights,
limitation of rights, and immunities of the Company, the Warrant Agent, and the holders of the Warrants; and

 

WHEREAS, all acts and things have been done
and performed which are necessary to make the Warrants, when executed on behalf of the Company and countersigned by or on behalf
of the Warrant Agthe Warrants, the termsent, as provided herein, the valid, binding and legal obligations of the Company, and to authorize the execution
and delivery of this Agreement.

 

    1

     

    

 

NOW, THEREFORE, in consideration of the
mutual agreements herein contained, the parties hereto agree as follows:

 

1. Appointment of Warrant Agent.
The Company hereby appoints the Warrant Agent to act as agent for the Company for the Warrants, and the Warrant Agent hereby accepts
such appointment and agrees to perform the same in accordance with the terms and conditions set forth in this Agreement.

 

2. Warrants.

 

2.1 Form of Warrant. Each
Warrant shall be issued in registered form only, and, if a physical certificate is issued, shall be in substantially the form of Exhibit
A hereto, the provisions of which are incorporated herein and shall be signed by, or bear the facsimile signature of,
the Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer, Secretary or other principal officer of
the Company. In the event the person whose facsimile signature has been placed upon any Warrant shall have ceased to serve in the
capacity in which such person signed the Warrant before such Warrant is issued, it may be issued with the same effect as if he
or she had not ceased to be such at the date of issuance. All of the Public Warrants shall initially be represented by one or more
book-entry certificates (each, a “Book-Entry Warrant Certificate”).

 

2.2 Effect of Countersignature.
If a physical certificate is issued, unless and until countersigned by the Warrant Agent pursuant to this Agreement, a Warrant
certificate shall be invalid and of no effect and may not be exercised by the holder thereof.

 

2.3 Registration.

 

2.3.1 Warrant Register. The
Warrant Agent shall maintain books (the “Warrant Register”) for the registration of
original issuance and the registration of transfer of the Warrants. Upon the initial issuance of the Warrants, the Warrant Agent
shall issue and register the Warrants in the names of the respective holders thereof in such denominations and otherwise in accordance
with instructions delivered to the Warrant Agent by the Company. All of the Public Warrants shall initially be represented by one
or more Book-Entry Warrant Certificates deposited with The Depository Trust Company (the “Depositary”)
and registered in the name of Cede & Co., a nominee of the Depositary. Ownership of beneficial interests in the Public Warrants
shall be shown on, and the transfer of such ownership shall be effected through, records maintained by (i) the Depositary or its
nominee for each Book-Entry Warrant Certificate, or (ii) institutions that have accounts with the Depositary (each such institution,
with respect to a Warrant in its account, a “Participant”).

 

If the Depositary subsequently ceases
to make its book-entry settlement system available for the Public Warrants, the Company may instruct the Warrant Agent regarding
making other arrangements for book-entry settlement. In the event that the Public Warrants are not eligible for, or it is no longer
necessary to have the Public Warrants available in, book-entry form, the Warrant Agent shall provide written instructions to the
Depositary to deliver to the Warrant Agent for cancellation each Book-Entry Warrant Certificate, and the Company shall instruct
the Warrant Agent to deliver to the Depositary definitive certificates in physical form evidencing such Warrants (“Definitive
Warrant Certificate”). Such Definitive Warrant Certificate shall be in the form annexed hereto as Exhibit
A, with appropriate insertions, modifications and omissions, as provided above.

 

2.3.2 Registered Holder. Prior
to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent may deem and treat the person
in whose name such Warrant is registered in the Warrant Register (the “Registered Holder”)
as the absolute owner of such Warrant and of each Warrant represented thereby (notwithstanding any notation of ownership or other
writing on a Definitive Warrant Certificate made by anyone other than the Company or the Warrant Agent), for the purpose of any
exercise thereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to
the contrary.

 

    2

     

    

 

2.4 Detachability of Warrants.
The Common Stock and Public Warrants comprising the Units shall begin separate trading on the 52nd day following the date of the
Prospectus or, if such 52nd day is not on a day, other than a Saturday, Sunday or federal holiday, on which banks in New York City
are generally open for normal business (a “Business Day”), then on the immediately
succeeding Business Day following such date, or earlier (the “Detachment Date”) with
the consent of Cantor Fitzgerald & Co., as representative of the several underwriters (the “Representative”),
but in no event shall the Common Stock and the Public Warrants comprising the Units be separately traded until (A) the Company
has filed a current report on Form 8-K with the Commission containing an audited balance sheet reflecting the receipt by the Company
of the gross proceeds of the Offering, including the proceeds received by the Company from the exercise by the underwriters of
their right to purchase additional Units in the Offering (the “Over-allotment Option”),
if the Over-allotment Option is exercised prior to the filing of the Form 8-K, and (B) the Company issues a press release and files
with the Commission a current report on Form 8-K announcing when such separate trading shall begin.

 

2.5 Fractional Warrants. The
Company shall not issue fractional Warrants other than as part of the Units, each of which is comprised of one share of Common
Stock and one-half of one Public Warrant. If, upon the detachment of Public Warrants from Units or otherwise, a holder of Warrants
would be entitled to receive a fractional Warrant, the Company shall round down to the nearest whole number of Warrants to be issued
to such holder.

 

2.6 Private Placement Warrants
and Working Capital Warrants. The Private Placement Warrants and the Working Capital Warrants shall be identical to the Public
Warrants, except that so long as they are held by the Sponsor or any Permitted Transferees (as defined below), as applicable, the
Private Placement Warrants and the Working Capital Warrants: (i) may be exercised for cash or on a cashless basis, pursuant to subsection
3.3.1(c) hereof, (ii) may not be transferred, assigned or sold until the date that is thirty (30) days after the completion
by the Company of an initial Business Combination (as defined below), and (iii) shall not be redeemable by the Company; provided, however,
that in the case of (ii) the Private Placement Warrants and the Working Capital Warrants and any shares of Common Stock held by
the Sponsor, any officers or directors of the Company or any Permitted Transferees, as applicable, and issued upon exercise of
the Private Placement Warrants and the Working Capital Warrants may be transferred by the holders thereof:

 

(a) to the Company’s officers or
directors, any affiliate or family member of any of the Company’s officers or directors, any affiliate of the Sponsor or
to any members of the Sponsor or any of their affiliates;

 

(b) in the case of an individual, by gift
to a member of such individual’s immediate family or to a trust, the beneficiary of which is a member of such individual’s
immediate family, an affiliate of such individual or to a charitable organization;

 

(c) in the case of an individual, by virtue
of laws of descent and distribution upon death of such person;

 

(d) in the case of an individual, pursuant
to a qualified domestic relations order;

 

(e) by private sales or transfers made
in connection with any forward purchase agreement or similar arrangement or in connection with the consummation of an initial Business
Combination at prices no greater than the price at which the Warrants were originally purchased;

 

(f) by virtue of the laws of the State
of Delaware or the limited liability company agreement of the Sponsor upon dissolution of the Sponsor;

 

    3

     

    

 

(g) in the event of the Company’s
liquidation prior to the consummation of a Business Combination; or

 

(h) in the event that, subsequent to the
consummation of a Business Combination, the Company completes a liquidation, merger, share exchange or other similar transaction
which results in all of the Company’s stockholders having the right to exchange their shares of Common Stock for cash, securities
or other property;

 

provided, however, that, in the case of clauses
(a) through (f), these transferees (the “Permitted Transferees”) enter into a written
agreement with the Company agreeing to be bound by the transfer restrictions in this Agreement and the other restrictions contained
in the letter agreement, dated as of the date hereof, by and among the Company, the Sponsor and the Company’s officers and
directors.

 

2.7 Working
Capital Warrants. The Working Capital Warrants shall be identical to the Private Placement Warrants.

 

2.8 Post-IPO
Warrants. The Post-IPO Warrants, when and if issued, shall have the same terms and be in the same form as the Public Warrants
except as may be agreed upon by the Company.

 

3. Terms and Exercise of Warrants.

 

3.1 Warrant Price. Each Warrant
shall entitle the Registered Holder thereof, subject to the provisions of such Warrant and of this Agreement, to purchase from
the Company the number of shares of Common Stock stated therein, at the price of $11.50 per share, subject to the adjustments provided
in Section 4 hereof and in the last sentence of this Section 3.1. The term “Warrant Price”
as used in this Agreement shall mean the price per share at which shares of Common Stock may be purchased at the time a Warrant
is exercised. The Company in its sole discretion may lower the Warrant Price at any time prior to the Expiration Date (as defined
below) for a period of not less than twenty (20) Business Days; provided, that the Company shall provide at least twenty (20) days’
prior written notice of such reduction to Registered Holders of the Warrants; and provided further, that any such reduction shall
be identical among all of the Warrants.

 

3.2 Duration of Warrants.
A Warrant may be exercised only during the period (the “Exercise Period”) commencing
on the later of: (i) the date that is thirty (30) days after the first date on which the Company completes a merger, capital stock
exchange, asset acquisition, stock purchase, reorganization or similar business combination, involving the Company and one or more
businesses (a “Business Combination”), and (ii) the date that is twelve (12) months
from the date of the closing of the Offering, and terminating at 5:00 p.m., New York City time on the earlier to occur of: (x)
the date that is five (5) years after the date on which the Company completes its initial Business Combination, (y) the liquidation
of the Company, or (z) other than with respect to the Private Placement Warrants and the Working Capital Warrants to the extent
then held by the original purchasers thereof or their Permitted Transferees, the Redemption Date (defined in Section 6.2)
as provided in Section 6 hereof (the Expiration Date”);  provided, however,
that the exercise of any Warrant shall be subject to the satisfaction of any applicable conditions, as set forth in subsection
3.3.2 below with respect to an effective registration statement. Except with respect to the right to receive the Redemption
Price (defined in Section 6.1) (other than with respect to a Private Placement Warrant or a Working Capital Warrant) to
the extent then held by the original purchasers thereof or their Permitted Transferees in the event of a redemption (as set forth
in Section 6 hereof), each outstanding Warrant (other than a Private Placement Warrant or a Working Capital Warrant
to the extent then held by the original purchasers thereof or their Permitted Transferees in the event of a redemption) not exercised
on or before the Expiration Date shall become void, and all rights thereunder and all rights in respect thereof under this Agreement
shall cease at 5:00 p.m. New York City time on the Expiration Date. The Company in its sole discretion may extend the duration
of the Warrants by delaying the Expiration Date; provided, that the Company shall provide at least twenty (20) days
prior written notice of any such extension to Registered Holders of the Warrants and, provided further that any such extension
shall be identical in duration among all the Warrants.

 

    4

     

    

 

3.3 Exercise of Warrants.

 

3.3.1 Payment. Subject to
the provisions of the Warrant and this Agreement, a Warrant may be exercised by the Registered Holder thereof by delivering to
the Warrant Agent at its corporate trust department (i) the Definitive Warrant Certificate evidencing the Warrants to be exercised,
or, in the case of a Book-Entry Warrant Certificate, the Warrants to be exercised (the “Book-Entry Warrants”)
on the records of the Depositary to an account of the Warrant Agent at the Depositary designated for such purposes in writing by
the Warrant Agent to the Depositary from time to time, (ii) an election to purchase (“Election to Purchase”)
shares of Common Stock pursuant to the exercise of a Warrant, properly completed and executed by the Registered Holder on the reverse
of the Definitive Warrant Certificate or, in the case of a Book-Entry Warrant Certificate, properly delivered by the Participant
in accordance with the Depositary’s procedures, and (iii) payment in full of the Warrant Price for each full share of Common
Stock as to which the Warrant is exercised and any and all applicable taxes due in connection with the exercise of the Warrant,
the exchange of the Warrant for the shares of Common Stock and the issuance of such shares of Common Stock, as follows:

 

(a) in lawful money of the United States,
in good certified check or good bank draft payable to the order of the Warrant Agent or by wire transfer of immediately available
funds;

 

(b) in the event of a redemption pursuant
to Section 6 hereof in which the Company’s board of directors (the “Board”) has
elected to require all holders of the Warrants to exercise such Warrants on a “cashless basis,” by surrendering the
Warrants for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number of
shares of Common Stock underlying the Warrants, multiplied by the excess of the Fair Market Value over the Warrant Price by (y)
the Fair Market Value. Solely for purposes of this subsection 3.3.1(b) and Section 6.3, “Fair
Market Value” shall mean the average closing price of the Common Stock for the ten (10) trading days ending on the
third trading day prior to the date on which the notice of redemption is sent to the holders of the Warrants, pursuant to Section
6 hereof;

 

(c) with respect to any Private Placement
Warrants or Working Capital Warrants, so long as such Private Placement Warrants or Working Capital Warrants are held by the original
purchaser thereof or its Permitted Transferee, by surrendering the Warrants for that number of shares of Common Stock equal to
the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the Warrants, multiplied by
the excess of the Fair Market Value over the Warrant Price by (y) the Fair Market Value. Solely for purposes of this subsection
3.3.1(c), “Fair Market Value” shall mean the average closing price of the Common Stock for the ten
(10) trading days ending on the third trading day prior to the date on which notice of exercise of the Private Placement Warrants
or Working Capital Warrants is sent to the Warrant Agent; or

 

(d) as provided in Section 7.4 hereof.

 

3.3.2 Issuance of Shares of Common
Stock on Exercise. As soon as practicable after the exercise of any Warrant and the clearance of the funds in payment of the
Warrant Price (if payment is pursuant to subsection 3.3.1(a)), the Company shall issue to the Registered Holder of
such Warrant a book-entry position or certificate, as applicable, for the number of full shares of Common Stock to which he, she
or it is entitled, registered in such name or names as may be directed by him, her or it, and if such Warrant shall not have been
exercised in full, a new book-entry position or countersigned Warrant, as applicable, for the number of shares of Common Stock
as to which such Warrant shall not have been exercised. If fewer than all the Warrants evidenced by a Book-Entry Warrant Certificate
are exercised, a notation shall be made to the records maintained by the Depositary, its nominee for each Book-Entry Warrant Certificate,
or a Participant, as appropriate, evidencing the balance of the Warrants remaining after such exercise. Notwithstanding the foregoing,
the Company shall not be obligated to deliver any shares of Common Stock pursuant to the exercise of a Warrant and shall have no
obligation to settle such Warrant exercise unless a registration statement under the Securities Act with respect to the shares
of Common Stock underlying the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company’s
satisfying its obligations under Section 7.4. No Warrant shall be exercisable and the Company shall not be obligated
to issue shares of Common Stock upon exercise of a Warrant unless the Common Stock issuable upon such Warrant exercise has been
registered, qualified or deemed to be exempt from registration or qualification under the securities laws of the state of residence
of the Registered Holder of the Warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied
with respect to a Warrant, the holder of such Warrant shall not be entitled to exercise such Warrant and such Warrant may have
no value and expire worthless, in which case the purchaser of a Unit containing such Public Warrants shall have paid the full purchase
price for the Unit solely for the shares of Common Stock underlying such Unit. In no event will the Company be required to net
cash settle the Warrant exercise. The Company may require holders of Public Warrants to settle the Warrant on a “cashless
basis” pursuant to Section 7.4. If, by reason of any exercise of Warrants on a “cashless basis”, the holder
of any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share of Common Stock,
the Company shall round down to the nearest whole number, the number of shares of Common Stock to be issued to such holder.

 

    5

     

    

3.3.3 Valid Issuance. All
shares of Common Stock issued upon the proper exercise of a Warrant in conformity with this Agreement shall be validly issued,
fully paid and non-assessable.

 

3.3.4 Date of Issuance. Each
person in whose name any book-entry position or certificate, as applicable, for shares of Common Stock is issued shall for all
purposes be deemed to have become the holder of record of such shares of Common Stock on the date on which the Warrant, or book-entry
position representing such Warrant, was surrendered and payment of the Warrant Price was made, irrespective of the date of delivery
of such certificate in the case of a certificated Warrant, except that, if the date of such surrender and payment is a date when
the share transfer books of the Company or book-entry system of the Warrant Agent are closed, such person shall be deemed to have
become the holder of such shares of Common Stock at the close of business on the next succeeding date on which the share transfer
books or book-entry system are open.

 

3.3.5 Maximum Percentage.
A holder of a Warrant may notify the Company in writing in the event it elects to be subject to the provisions contained in this subsection
3.3.5; however, no holder of a Warrant shall be subject to this subsection 3.3.5 unless he, she
or it makes such election. If the election is made by a holder, the Warrant Agent shall not effect the exercise of the holder’s
Warrant, and such holder shall not have the right to exercise such Warrant, to the extent that after giving effect to such exercise,
such person (together with such person’s affiliates), to the Warrant Agent’s actual knowledge, would beneficially own
in excess of 4.9% or 9.8% (or such other amount as a holder may specify)(the “Maximum Percentage”)
of the shares of Common Stock outstanding immediately after giving effect to such exercise. For purposes of the foregoing sentence,
the aggregate number of shares of Common Stock beneficially owned by such person and its affiliates shall include the number of
shares of Common Stock issuable upon exercise of the Warrant with respect to which the determination of such sentence is being
made, but shall exclude shares of Common Stock that would be issuable upon (x) exercise of the remaining, unexercised portion of
the Warrant beneficially owned by such person and its affiliates and (y) exercise or conversion of the unexercised or unconverted
portion of any other securities of the Company beneficially owned by such person and its affiliates (including, without limitation,
any convertible notes or convertible preferred stock or warrants) subject to a limitation on conversion or exercise analogous to
the limitation contained herein. Except as set forth in the preceding sentence, for purposes of this paragraph, beneficial ownership
shall be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).
For purposes of the Warrant, in determining the number of outstanding shares of Common Stock, the holder may rely on the number
of outstanding shares of Common Stock as reflected in (1) the Company’s most recent Annual Report on Form 10-K, Quarterly
Report on Form 10-Q, Current Report on Form 8-K or other public filing with the Commission as the case may be, (2) a more recent
public announcement by the Company or (3) any other notice by the Company or the Transfer Agent setting forth the number of shares
of Common Stock outstanding. For any reason at any time, upon the written request of the holder of the Warrant, the Company shall,
within two (2) Business Days, confirm orally and in writing to such holder the number of shares of Common Stock then outstanding.
In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise
of equity securities of the Company by the holder and its affiliates since the date as of which such number of outstanding shares
of Common Stock was reported. By written notice to the Company, the holder of a Warrant may from time to time increase or decrease
the Maximum Percentage applicable to such holder to any other percentage specified in such notice; provided, however,
that any such increase shall not be effective until the sixty-first (61st) day after such notice is delivered to the Company.

 

    6

     

    

 

4. Adjustments.

 

4.1 Stock Dividends.

 

4.1.1 Split-Ups. If after
the date hereof, and subject to the provisions of Section 4.6 below, the number of outstanding shares of Common
Stock is increased by a stock dividend payable in shares of Common Stock, or by a split-up of shares of Common Stock or other similar
event, then, on the effective date of such stock dividend, split-up or similar event, the number of shares of Common Stock issuable
on exercise of each Warrant shall be increased in proportion to such increase in the outstanding shares of Common Stock. A rights
offering to holders of the Common Stock entitling holders to purchase shares of Common Stock at a price less than the Fair Market
Value shall be deemed a stock dividend of a number of shares of Common Stock equal to the product of (i) the number of shares of
Common Stock actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering
that are convertible into or exercisable for the Common Stock) multiplied by (ii) one (1) minus the quotient of (x) the price per
share of Common Stock paid in such rights offering divided by (y) the Fair Market Value. For purposes of this subsection
4.1.1, (i) if the rights offering is for securities convertible into or exercisable for Common Stock, in determining the price
payable for Common Stock, there shall be taken into account any consideration received for such rights, as well as any additional
amount payable upon exercise or conversion and (ii) “Fair Market Value” means the volume weighted average
price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the first date
on which the shares of Common Stock trade on the applicable exchange or in the applicable market, regular way, without the right
to receive such rights.

 

4.1.2 Extraordinary Dividends.
If the Company, at any time while the Warrants are outstanding and unexpired, shall pay a dividend or make a distribution in cash,
securities or other assets to the holders of the Common Stock on account of such shares of Common Stock (or other shares of the
Company’s capital stock into which the Warrants are convertible), other than (a) as described in subsection 4.1.1 above,
(b) Ordinary Cash Dividends (as defined below), (c) to satisfy the redemption rights of the holders of the Common Stock in connection
with a proposed initial Business Combination, (d) to satisfy the redemption rights of the holders of Common Stock in connection
with a stockholder vote to amend the Company’s amended and restated certificate of incorporation (as amended from time to
time, the “Charter”) to modify the substance or timing of the Company’s obligation to redeem 100%
of the shares of Common Stock included in the Units sold in the Offering if the Company does not complete the Business Combination
within the period set forth in the Charter or with respect to any other material provisions relating to stockholders’ rights
or pre-initial Business Combination activity, or to provide for redemption in connection with a Business Combination or (e) in
connection with the redemption of public shares of Common Stock included in the Units sold in the Offering upon the failure of
the Company to complete its initial Business Combination and any subsequent distribution of its assets upon its liquidation (any
such non-excluded event being referred to herein as an “Extraordinary Dividend”),
then the Warrant Price shall be decreased, effective immediately after the effective date of such Extraordinary Dividend, by the
amount of cash and/or the fair market value (as determined by the Board, in good faith) of any securities or other assets paid
on each share of Common Stock in respect of such Extraordinary Dividend. For purposes of this subsection 4.1.2, “Ordinary Cash Dividends”
means any cash dividend or cash distribution which, when combined on a per share basis, with the per share amounts of all other
cash dividends and cash distributions paid on the Common Stock during the 365-day period ending on the date of declaration of such
dividend or distribution (as adjusted to appropriately reflect any of the events referred to in other subsections of this Section
4 and excluding cash dividends or cash distributions that resulted in an adjustment to the Warrant Price or to the number
of shares of Common Stock issuable on exercise of each Warrant) does not exceed $0.50 (being 5% of the offering price of the Units
in the Offering).

 

4.2 Aggregation of Shares.
If after the date hereof, and subject to the provisions of Section 4.6 hereof, the number of outstanding shares
of Common Stock is decreased by a consolidation, combination, reverse stock split or reclassification of shares of Common Stock
or other similar event, then, on the effective date of such consolidation, combination, reverse stock split, reclassification or
similar event, the number of shares of Common Stock issuable on exercise of each Warrant shall be decreased in proportion to such
decrease in outstanding shares of Common Stock.

 

    7

     

    

 

4.3 Adjustments in Warrant Price.

 

4.3.1 Whenever the number of shares of
Common Stock purchasable upon the exercise of the Warrants is adjusted, as provided in subsection 4.1.1 or Section
4.2 above, the Warrant Price shall be adjusted (to the nearest cent) by multiplying such Warrant Price immediately prior
to such adjustment by a fraction (x) the numerator of which shall be the number of shares of Common Stock purchasable upon the
exercise of the Warrants immediately prior to such adjustment, and (y) the denominator of which shall be the number of shares of
Common Stock so purchasable immediately thereafter.

 

4.3.2 If (x) the Company issues additional
shares of Common Stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business
Combination at an issue price or effective issue price of less than $9.20 per share of Common Stock (with such issue price or effective
issue price to be determined in good faith by the Board and, in the case of any such issuance to the initial stockholders (as defined
in the Prospectus) or their affiliates, without taking into account any shares of Class B Common Stock (as defined below in Section
4.9) held by such stockholders or their affiliates, as applicable, prior to such issuance (the “Newly Issued Price”)),
(y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon,
available for funding the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price
of the Common Stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates
the Business Combination (such price, the “Market Value”) is below $9.20 per share, the Warrant Price
shall be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the
last sales price of the Common Stock that triggers the Company’s right to redeem the Warrants pursuant to Section 6.1
below shall be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.

 

4.4 Replacement of Securities
upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding shares of Common Stock (other
than a change under subsections 4.1.1 or 4.1.2 or Section 4.2 hereof or that
solely affects the par value of such shares of Common Stock), or in the case of any merger or consolidation of the Company with
or into another entity or conversion of the Company as another entity (other than a consolidation or merger in which the Company
is the continuing corporation (and is not a subsidiary of another entity whose stockholders did not own all or substantially all
of the Common Stock of the Company in substantially the same proportions immediately before such transaction) and that does not
result in any reclassification or reorganization of the outstanding shares of Common Stock), or in the case of any sale or conveyance
to another entity of the assets or other property of the Company as an entirety or substantially as an entirety in connection with
which the Company is dissolved, the holders of the Warrants shall thereafter have the right to purchase and receive, upon the basis
and upon the terms and conditions specified in the Warrants and in lieu of the shares of Common Stock of the Company immediately
theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock
or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation,
or upon a dissolution following any such sale or transfer, that the holder of the Warrants would have received if such holder had
exercised his, her or its Warrant(s) immediately prior to such event (the “Alternative Issuance”
); provided, however, that (i) if the holders of the Common Stock were entitled to exercise a right of
election as to the kind or amount of securities, cash or other assets receivable upon such consolidation or merger, then the kind
and amount of securities, cash or other assets constituting the Alternative Issuance for which each Warrant shall become exercisable
shall be deemed to be the weighted average of the kind and amount received per share by the holders of the Common Stock in such
consolidation or merger that affirmatively make such election, and (ii) if a tender, exchange or redemption offer shall have been
made to and accepted by the holders of the Common Stock (other than a tender, exchange or redemption offer made by the Company
in connection with redemption rights held by stockholders of the Company as provided for in the Charter or as a result of the redemption
of shares of Common Stock by the Company if a proposed initial Business Combination is presented to the stockholders of the Company
for approval) under circumstances in which, upon completion of such tender or exchange offer, the maker thereof, together with
members of any group (within the meaning of Rule 13d-5(b)(1) under the Exchange Act (or any successor rule)) of which such maker
is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2 under the Exchange Act
(or any successor rule)) and any members of any such group of which any such affiliate or associate is a part, own beneficially
(within the meaning of Rule 13d-3 under the Exchange Act (or any successor rule)) more than 50% of the outstanding shares of Common
Stock, the holder of a Warrant shall be entitled to receive as the Alternative Issuance, the highest amount of cash, securities
or other property to which such holder would actually have been entitled as a stockholder if such Warrant holder had exercised
the Warrant prior to the expiration of such tender or exchange offer, accepted such offer and all of the Common Stock held by such
holder had been purchased pursuant to such tender or exchange offer, subject to adjustments (from and after the consummation of
such tender or exchange offer) as nearly equivalent as possible to the adjustments provided for in this Section 4; provided, further,
that if less than 70% of the consideration receivable by the holders of the Common Stock in the applicable event is payable in
the form of common stock in the successor entity that is listed for trading on a national securities exchange or is quoted in an
established over-the-counter market, or is to be so listed for trading or quoted immediately following such event, and if the Registered
Holder properly exercises the Warrant within thirty (30) days following the public disclosure of the consummation of such applicable
event by the Company pursuant to a Current Report on Form 8-K filed with the Commission, the Warrant Price shall be reduced by
an amount (in dollars) equal to the difference (but in no event less than zero) of (i) the Warrant Price in effect prior to such
reduction minus (ii) (A) the Per Share Consideration (as defined below) minus (B) the Black-Scholes Warrant Value (as defined below).
The “Black-Scholes Warrant Value” means the value of a Warrant
immediately prior to the consummation of the applicable event based on the Black-Scholes Warrant Model for a Capped American Call
on Bloomberg Financial Markets (“Bloomberg”). For purposes of calculating such amount, (1) Section
6 of this Agreement shall be taken into account, (2) the price of each share of Common Stock shall be the volume weighted
average price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the effective
date of the applicable event, (3) the assumed volatility shall be the 90 day volatility obtained from the HVT function on Bloomberg
determined as of the trading day immediately prior to the day of the announcement of the applicable event, and (4) the assumed
risk-free interest rate shall correspond to the U.S. Treasury rate for a period equal to the remaining term of the Warrant. “Per Share Consideration”
means (i) if the consideration paid to holders of the Common Stock consists exclusively of cash, the amount of such cash per share
of Common Stock, and (ii) in all other cases, the amount of cash per share of Common Stock, if any, plus the volume weighted average
price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the effective date
of the applicable event. If any reclassification or reorganization also results in a change in shares of Common Stock covered by subsection
4.1.1, then such adjustment shall be made pursuant to subsection 4.1.1 or Sections 4.2, 4.3 and
this Section 4.4. The provisions of this Section 4.4 shall similarly apply to successive reclassifications,
reorganizations, mergers or consolidations, sales or other transfers. In no event will the Warrant Price be reduced to less than
the par value per share issuable upon exercise of the Warrant.

 

    8

     

    

 

4.5 Notices of Changes in Warrant.
Upon every adjustment of the Warrant Price or the number of shares of Common Stock issuable upon exercise of a Warrant, the Company
shall give written notice thereof to the Warrant Agent, which notice shall state the Warrant Price resulting from such adjustment
and the increase or decrease, if any, in the number of shares of Common Stock purchasable at such price upon the exercise of a
Warrant, setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based. Upon
the occurrence of any event specified in Sections 4.1, 4.2, 4.3 or 4.4, the
Company shall give written notice of the occurrence of such event to each holder of a Warrant, at the last address set forth for
such holder in the Warrant Register, of the record date or the effective date of the event. Failure to give such notice, or any
defect therein, shall not affect the legality or validity of such event.

 

4.6 No Fractional Shares.
Notwithstanding any provision contained in this Agreement to the contrary, the Company shall not issue fractional shares of Common
Stock upon the exercise of Warrants. If, by reason of any adjustment made pursuant to this Section 4, the holder of
any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share, the Company shall,
upon such exercise, round down to the nearest whole number the number of shares of Common Stock to be issued to such holder.

 

4.7 Form of Warrant. The form
of Warrant need not be changed because of any adjustment pursuant to this Section 4, and Warrants issued after such
adjustment may state the same Warrant Price and the same number of shares of Common Stock as is stated in the Warrants initially
issued pursuant to this Agreement; provided, however, that the Company may at any time in its sole discretion
make any change in the form of Warrant that the Company may deem appropriate and that does not affect the substance thereof, and
any Warrant thereafter issued or countersigned, whether in exchange or substitution for an outstanding Warrant or otherwise, may
be in the form as so changed.

 

    9

     

    

 

4.8 Other Events. In case
any event shall occur affecting the Company as to which none of the provisions of the preceding subsections of this Section
4 are strictly applicable, but which would require an adjustment to the terms of the Warrants in order to (i) avoid an
adverse impact on the Warrants and (ii) effectuate the intent and purpose of this Section 4, then, in each such case,
the Company shall appoint a firm of independent public accountants, investment banking or other appraisal firm of recognized national
standing, which shall give its opinion as to whether or not any adjustment to the rights represented by the Warrants is necessary
to effectuate the intent and purpose of this Section 4 and, if they determine that an adjustment is necessary,
the terms of such adjustment. The Company shall adjust the terms of the Warrants in a manner that is consistent with any adjustment
recommended in such opinion.

 

4.9 No Adjustment. For the
avoidance of doubt, no adjustment shall be made to the terms of the Warrants solely as a result of an adjustment to the conversion
ratio of the Company’s Class B common stock (the “Class B Common Stock”) into shares of Common
Stock or the conversion of the shares of Class B Common Stock into shares of Common Stock, in each case, pursuant to the Charter.

 

5. Transfer and Exchange of Warrants.

 

5.1 Registration of Transfer.
The Warrant Agent shall register the transfer, from time to time, of any outstanding Warrant upon the Warrant Register, upon surrender
of such Warrant for transfer, in the case of a certificated Warrant, properly endorsed with signatures properly guaranteed and
accompanied by appropriate instructions for transfer. Upon any such transfer, a new Warrant representing an equal aggregate number
of Warrants shall be issued and the old Warrant shall be cancelled by the Warrant Agent. In the case of certificated Warrants,
the Warrants so cancelled shall be delivered by the Warrant Agent to the Company from time to time upon request.

 

5.2 Procedure for Surrender of
Warrants. Warrants may be surrendered to the Warrant Agent, together with a written request for exchange or transfer, and thereupon
the Warrant Agent shall issue in exchange therefor one or more new Warrants as requested by the Registered Holder of the Warrants
so surrendered, representing an equal aggregate number of Warrants; provided, however, that except as otherwise
provided herein or in any Book-Entry Warrant Certificate or Definitive Warrant Certificate, each Book-Entry Warrant Certificate
and Definitive Warrant Certificate may be transferred only in whole and only to the Depositary, to another nominee of the Depositary,
to a successor depository, or to a nominee of a successor depository; provided further, however,
that in the event that a Warrant surrendered for transfer bears a restrictive legend (as in the case of the Private Placement Warrants
and the Working Capital Warrants), the Warrant Agent shall not cancel such Warrant and issue new Warrants in exchange thereof until
the Warrant Agent has received an opinion of counsel for the Company stating that such transfer may be made and indicating whether
the new Warrants must also bear a restrictive legend.

 

5.3 Fractional Warrants. The
Warrant Agent shall not be required to effect any registration of transfer or exchange which shall result in the issuance of a
warrant certificate or book-entry position for a fraction of a warrant, except as part of the Units.

 

5.4 Service Charges. No service
charge shall be made for any exchange or registration of transfer of Warrants.

 

5.5 Warrant Execution and Countersignature.
The Warrant Agent is hereby authorized to countersign and to deliver, in accordance with the terms of this Agreement, the Warrants
required to be issued pursuant to the provisions of this Section 5, and the Company, whenever required by the Warrant
Agent, shall supply the Warrant Agent with Warrants duly executed on behalf of the Company for such purpose.

 

    10

     

    

 

5.6 Transfer of Warrants.
Prior to the Detachment Date, the Public Warrants may be transferred or exchanged only together with the Unit in which such Warrant
is included, and only for the purpose of effecting, or in conjunction with, a transfer or exchange of such Unit. Furthermore, each
transfer of a Unit on the register relating to such Units shall operate also to transfer the Warrants included in such Unit. Notwithstanding
the foregoing, the provisions of this Section 5.6 shall have no effect on any transfer of Warrants on and after
the Detachment Date.

 

6. Redemption.

 

6.1 Redemption of Warrants.
Subject to Section 6.4 hereof, not less than all of the outstanding Warrants may be redeemed, at the option of
the Company, at any time while they are exercisable and prior to their expiration, at the office of the Warrant Agent, upon notice
to the Registered Holders of the Warrants, as described in Section 6.2 below, at the price of $0.01 per Warrant
(the “Redemption Price”), provided that the closing price of the Common
Stock reported has been at least $18.00 per share (subject to adjustment in compliance with Section 4 hereof),
on each of twenty (20) trading days within the thirty (30) trading-day period commencing once the Warrants become exercisable and
ending on the third trading day prior to the date on which notice of the redemption is given; provided further that
there is an effective registration statement covering the shares of Common Stock issuable upon exercise of the Warrants, and a
current prospectus relating thereto, available throughout the 30-day Redemption Period (as defined in Section 6.2 below)
or the Company has elected to require the exercise of the Warrants on a “cashless basis” pursuant to subsection
3.3.1 and such cashless exercise is exempt from registration under the Securities Act.

 

6.2 Date Fixed for, and Notice
of, Redemption. In the event that the Company elects to redeem all of the Warrants pursuant to Section 6.1, the Company
shall fix a date for the redemption (the “Redemption Date”). Notice of redemption
shall be mailed by first class mail, postage prepaid, by the Company not less than thirty (30) days prior to the Redemption Date
(such period, the “Redemption Period”) to the Registered Holders of the Warrants to
be redeemed at their last addresses as they shall appear on the registration books. Any notice mailed in the manner herein provided
shall be conclusively presumed to have been duly given whether or not the Registered Holder received such notice.

 

6.3 Exercise After Notice of Redemption.
The Warrants may be exercised, for cash (or on a “cashless basis” in accordance with subsection 3.3.1(b) of
this Agreement) at any time after notice of redemption shall have been given by the Company pursuant to Section 6.2 hereof
and prior to the Redemption Date. In the event that the Company determines to require all holders of Warrants to exercise their
Warrants on a “cashless basis” pursuant to subsection 3.3.1, the notice of redemption shall contain the
information necessary to calculate the number of shares of Common Stock to be received upon exercise of the Warrants, including
the Fair Market Value (as such term is defined in subsection 3.3.1(b) hereof) in such case. On and after the Redemption
Date, the record holder of the Warrants shall have no further rights except to receive, upon surrender of the Warrants, the Redemption
Price.

 

6.4 Exclusion of Certain Warrants.
The Company agrees that the redemption rights provided in Section 6.1 shall not apply to the Private Placement
Warrants, the Working Capital Warrants or the Post-IPO Warrants (if such Post-IPO Warrants provide that they are non-redeemable
by the Company) if at the time of the redemption such Private Placement Warrants, Working Capital Warrants or Post-IPO Warrants
continue to be held by the original purchasers thereof or their Permitted Transferees, as applicable. However, once such Private
Placement Warrants, Working Capital Warrants or Post-IPO Warrants are transferred (other than to Permitted Transferees under Section
2.6), the Company may redeem the Private Placement Warrants, the Working Capital Warrants or the Post-IPO Warrants (if the
Post-IPO Warrants permit such redemption by their terms) pursuant to Section 6.1 hereof, provided that the criteria
for redemption are met, including the opportunity of the holder of such Private Placement Warrants, Working Capital Warrants or
Post-IPO Warrants to exercise the Private Placement Warrants, the Working Capital Warrants or the Post-IPO Warrants prior to redemption
pursuant to Section 6.1. The Private Placement Warrants, the Working Capital Warrants or the Post-IPO Warrants (if
such Post-IPO Warrants provide that they are non-redeemable by the Company) that are transferred to persons other than Permitted
Transferees shall upon such transfer cease to be Private Placement Warrants, Working Capital Warrants or Post-IPO Warrants and
shall become Public Warrants under this Agreement.

 

    11

     

    

 

7. Other Provisions Relating to
Rights of Holders of Warrants.

 

7.1 No Rights as Stockholder.
A Warrant does not entitle the Registered Holder thereof to any of the rights of a stockholder of the Company, including, without
limitation, the right to receive dividends, or other distributions, exercise any preemptive rights to vote or to consent or to
receive notice as stockholders in respect of the meetings of stockholders or the election of directors of the Company or any other
matter.

 

7.2 Lost, Stolen, Mutilated, or
Destroyed Warrants. If any Warrant is lost, stolen, mutilated, or destroyed, the Company and the Warrant Agent may on such
terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case of a mutilated Warrant, include
the surrender thereof), issue a new Warrant of like denomination, tenor, and date as the Warrant so lost, stolen, mutilated, or
destroyed. Any such new Warrant shall constitute a substitute contractual obligation of the Company, whether or not the allegedly
lost, stolen, mutilated, or destroyed Warrant shall be at any time enforceable by anyone.

 

7.3 Reservation of Common Stock.
The Company shall at all times reserve and keep available a number of its authorized but unissued shares of Common Stock that shall
be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Agreement.

 

7.4 Registration of Common Stock;
Cashless Exercise at Company’s Option.

 

7.4.1 Registration of the Common
Stock. The Company agrees that as soon as practicable, but in no event later than fifteen (15) Business Days after the closing
of its initial Business Combination, it shall use its best efforts to file with the Commission a registration statement registering,
under the Securities Act, the issuance of the shares of Common Stock issuable upon exercise of the Warrants. The Company shall
use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and
a current prospectus relating thereto, until the expiration of the Warrants in accordance with the provisions of this Agreement.
If any such registration statement has not been declared effective by the 60th Business Day following the closing of the Business
Combination, holders of the Warrants shall have the right, during the period beginning on the 61st Business Day after the closing
of the Business Combination and ending upon such registration statement being declared effective by the Commission, and during
any other period when the Company shall fail to have maintained an effective registration statement covering the shares of Common
Stock issuable upon exercise of the Warrants, to exercise such Warrants on a “cashless basis,” by exchanging the Warrants
(in accordance with Section 3(a)(9) of the Securities Act (or any successor rule) or another exemption) for that number of shares
of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the
Warrants, multiplied by the excess of the Fair Market Value over the Warrant Price by (y) the Fair Market Value. Solely for purposes
of this subsection 7.4.1, “Fair Market Value” shall mean the average closing price of the
Common Stock as reported for the ten (10) trading day period ending on the trading day prior to the date that notice of exercise
is received by the Warrant Agent from the holder of such Warrants or its securities broker or intermediary. The date that notice
of cashless exercise is received by the Warrant Agent shall be conclusively determined by the Warrant Agent. In connection with
the “cashless exercise” of a Public Warrant, the Company shall, upon request, provide the Warrant Agent with an opinion
of counsel for the Company (which shall be an outside law firm with securities law experience) stating that (i) the exercise of
the Warrants on a cashless basis in accordance with this subsection 7.4.1 is not required to be registered under
the Securities Act and (ii) the shares of Common Stock issued upon such exercise shall be freely tradable under United States federal
securities laws by anyone who is not an affiliate (as such term is defined in Rule 144 under the Securities Act (or any successor
rule)) of the Company and, accordingly, shall not be required to bear a restrictive legend. Except as provided in subsection
7.4.2, for the avoidance of any doubt, unless and until all of the Warrants have been exercised or have expired, the Company
shall continue to be obligated to comply with its registration obligations under the first three sentences of this subsection
7.4.1.

 

    12

     

    

 

7.4.2 Cashless Exercise at Company’s
Option. If the Common Stock is at the time of any exercise of a Warrant not listed on a national securities exchange such that
it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act (or any successor
rule), the Company may, at its option, require holders of Public Warrants who exercise Public Warrants to exercise such Public
Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act (or any successor rule) as
described in subsection 7.4.1 and (i) in the event the Company so elects, the Company shall not be required to
file or maintain in effect a registration statement for the registration, under the Securities Act, of the Common Stock issuable
upon exercise of the Warrants, notwithstanding anything in this Agreement to the contrary or (ii) if the Company does not so elect,
the Company agrees to use its best efforts to register or qualify for sale the Common Stock issuable upon exercise of the Public
Warrants under the blue sky laws of the state of residence of the exercising Public Warrant holder to the extent an exemption is
not available.

 

8. Concerning the Warrant Agent
and Other Matters.

 

8.1 Payment of Taxes. The
Company shall from time to time promptly pay all taxes and charges that may be imposed upon the Company or the Warrant Agent in
respect of the issuance or delivery of shares of Common Stock upon the exercise of the Warrants, but the Company shall not be obligated
to pay any transfer taxes in respect of the Warrants or such shares of Common Stock.

 

8.2 Resignation, Consolidation,
or Merger of Warrant Agent.

 

8.2.1 Appointment of Successor
Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties and be discharged from
all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the Company. If the office
of the Warrant Agent becomes vacant by resignation or incapacity to act or otherwise, the Company shall appoint in writing a successor
Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such appointment within a period of thirty (30)
days after it has been notified in writing of such resignation or incapacity by the Warrant Agent or by the holder of a Warrant
(who shall, with such notice, submit the holder’s Warrant for inspection by the Company), then the holder of any Warrant
may apply to the Supreme Court of the State of New York for the County of New York for the appointment of a successor Warrant Agent
at the Company’s cost. Any successor Warrant Agent, whether appointed by the Company or by such court, shall be a corporation
organized and existing under the laws of the State of New York, in good standing and having its principal office in the Borough
of Manhattan, City and State of New York, and authorized under such laws to exercise corporate trust powers and subject to supervision
or examination by federal or state authority. After appointment, any successor Warrant Agent shall be vested with all the authority,
powers, rights, immunities, duties, and obligations of its predecessor Warrant Agent with like effect as if originally named as
Warrant Agent hereunder, without any further act or deed; but if for any reason it becomes necessary or appropriate, the predecessor
Warrant Agent shall execute and deliver, at the expense of the Company, an instrument transferring to such successor Warrant Agent
all the authority, powers, and rights of such predecessor Warrant Agent hereunder; and upon request of any successor Warrant Agent
the Company shall make, execute, acknowledge, and deliver any and all instruments in writing for more fully and effectually vesting
in and confirming to such successor Warrant Agent all such authority, powers, rights, immunities, duties, and obligations.

 

8.2.2 Notice of Successor Warrant
Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give notice thereof to the predecessor
Warrant Agent and the Transfer Agent for the Common Stock not later than the effective date of any such appointment.

 

8.2.3 Merger or Consolidation
of Warrant Agent. Any corporation into which the Warrant Agent may be merged or with which it may be consolidated or any corporation
resulting from any merger or consolidation to which the Warrant Agent shall be a party shall be the successor Warrant Agent under
this Agreement without any further act.

 

    13

     

    

 

8.3 Fees and Expenses of Warrant
Agent.

 

8.3.1 Remuneration. The Company
agrees to pay the Warrant Agent reasonable remuneration for its services as such Warrant Agent hereunder and shall, pursuant to
its obligations under this Agreement, reimburse the Warrant Agent upon demand for all expenditures that the Warrant Agent may reasonably
incur in the execution of its duties hereunder.

 

8.3.2 Further Assurances.
The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed, executed, acknowledged, and delivered
all such further and other acts, instruments, and assurances as may reasonably be required by the Warrant Agent for the carrying
out or performing of the provisions of this Agreement.

 

8.4 Liability of Warrant Agent.

 

8.4.1 Reliance on Company Statement.
Whenever in the performance of its duties under this Agreement, the Warrant Agent shall deem it necessary or desirable that any
fact or matter be proved or established by the Company prior to taking or suffering any action hereunder, such fact or matter (unless
other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved and established by
a statement signed by the Chief Executive Officer, Chief Financial Officer, President, Executive Vice President, Vice President,
Secretary or Chairman of the Board of the Company and delivered to the Warrant Agent. The Warrant Agent may rely upon such statement
for any action taken or suffered in good faith by it pursuant to the provisions of this Agreement.

 

8.4.2 Indemnity. The Warrant
Agent shall be liable hereunder only for its own gross negligence, willful misconduct or bad faith. The Company agrees to indemnify
the Warrant Agent and save it harmless against any and all liabilities, including judgments, costs and reasonable counsel fees,
for anything done or omitted by the Warrant Agent in the execution of this Agreement, except as a result of the Warrant Agent’s
gross negligence, willful misconduct or bad faith.

 

8.4.3 Exclusions. The Warrant
Agent shall have no responsibility with respect to the validity of this Agreement or with respect to the validity or execution
of any Warrant (except its countersignature thereof). The Warrant Agent shall not be responsible for any breach by the Company
of any covenant or condition contained in this Agreement or in any Warrant. The Warrant Agent shall not be responsible to make
any adjustments required under the provisions of Section 4 hereof or responsible for the manner, method, or amount
of any such adjustment or the ascertaining of the existence of facts that would require any such adjustment; nor shall it by any
act hereunder be deemed to make any representation or warranty as to the authorization or reservation of any shares of Common Stock
to be issued pursuant to this Agreement or any Warrant or as to whether any shares of Common Stock shall, when issued, be valid
and fully paid and non-assessable.

 

8.5 Acceptance of Agency.
The Warrant Agent hereby accepts the agency established by this Agreement and agrees to perform the same upon the terms and conditions
herein set forth and among other things, shall account promptly to the Company with respect to Warrants exercised and concurrently
account for, and pay to the Company, all monies received by the Warrant Agent for the purchase of shares of Common Stock through
the exercise of the Warrants.

 

8.6 Waiver. The Warrant Agent
has no right of set-off or any other right, title, interest or claim of any kind (“Claim”) in, or to
any distribution of, the Trust Account (as defined in that certain Investment Management Trust Agreement, dated as of the date
hereof, by and between the Company and the Warrant Agent as trustee thereunder) and hereby agrees not to seek recourse, reimbursement,
payment or satisfaction for any Claim against the Trust Account for any reason whatsoever. The Warrant Agent hereby waives any
and all Claims against the Trust Account and any and all rights to seek access to the Trust Account.

 

    14

     

    

 

9. Miscellaneous Provisions.

 

9.1 Successors. All the covenants
and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall bind and inure to the benefit
of their respective successors and assigns.

 

9.2 Notices. Any notice, statement
or demand authorized by this Agreement to be given or made by the Warrant Agent or by the holder of any Warrant to or on the Company
shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier
service within five (5) days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing
by the Company with the Warrant Agent), as follows:

 

IG Acquisition Corp.

251 Park Avenue South, 8th Floor

New York, New York 10010

Attention: Christian Goode, Chief Executive Officer

 

Any notice, statement or demand authorized by this Agreement
to be given or made by the holder of any Warrant or by the Company to or on the Warrant Agent shall be sufficiently given when
so delivered if by hand or overnight delivery or if sent by certified mail or private courier service within five (5) days after
deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Warrant Agent with the Company),
as follows:

 

Continental Stock Transfer & Trust
Company

1 State Street, 30th Floor

New York, NY 10004

Attention: Compliance Department

 

In each case, with copies to:

 

Ellenoff Grossman & Schole LLP

1345 Avenue of the Americas

New York, NY 10105

Attn: Douglas S. Ellenoff

          Stuart
Neuhauser

Email: ellenoff@egsllp.com

          
sneuhauser@egsllp.com

 

and

 

Graubard Miller

The Chrysler Building

405 Lexington Avenue, 11th Floor

New York, NY 10174

Attn: David Alan Miller

Jeffrey M. Gallant

Email: dmiller@graubard.com

          
jgallant@graubard.com

 

    15

     

    

 

9.3 Applicable Law; Exclusive
Forum. The validity, interpretation, and performance of this Agreement and of the Warrants shall be governed in all respects
by the laws of the State of New York, without giving effect to conflicts of law principles that would result in the application
of the substantive laws of another jurisdiction. The Company hereby agrees that any action, proceeding or claim against it arising
out of or relating in any way to this Agreement shall be brought and enforced in the courts of the State of New York or the United
States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall
be the exclusive forum for any such action, proceeding or claim. The Company hereby waives any objection to such exclusive jurisdiction
and that such courts represent an inconvenient forum. Notwithstanding the foregoing, the provisions of this paragraph will not
apply to suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the federal district
courts of the United States of America are the sole and exclusive forum.

 

Any person or entity purchasing or otherwise
acquiring any interest in the Warrants shall be deemed to have notice of and to have consented to the forum provisions in this
Section 9.3. If any action, the subject matter of which is within the scope the forum provisions above, is filed in a court
other than a court located within the State of New York or the United States District Court for the Southern District of New York
(a “Foreign Action”) in the name of any warrant holder, such warrant holder shall be deemed to have consented
to: (x) the personal jurisdiction of the state and federal courts located within the State of New York or the United States District
Court for the Southern District of New York in connection with any action brought in any such court to enforce the forum provisions
(an “Enforcement Action”), and (y) having service of process made upon such warrant holder in any Enforcement
Action by service upon such warrant holder’s counsel in the Foreign Action as agent for such warrant holder.

 

9.4 Persons Having Rights under
this Agreement. Nothing in this Agreement shall be construed to confer upon, or give to, any person or corporation other than
the parties hereto and the Registered Holders of the Warrants and, for purposes of Sections 7.4, 9.4 and 9.8, the Representative,
any right, remedy, or claim under or by reason of this Agreement or of any covenant, condition, stipulation, promise, or agreement
hereof. All covenants, conditions, stipulations, promises, and agreements contained in this Agreement shall be for the sole and
exclusive benefit of the parties hereto and, for purposes of Sections 7.4, 9.4 and 9.8, the Representative, and their successors
and assigns and of the Registered Holders of the Warrants.

 

9.5 Examination of the Warrant
Agreement. A copy of this Agreement shall be available at all reasonable times at the office of the Warrant Agent in the Borough
of Manhattan, City and State of New York, for inspection by the Registered Holder of any Warrant. The Warrant Agent may require
any such holder to submit such holder’s Warrant for inspection by the Warrant Agent.

 

9.6 Counterparts. This Agreement
may be executed in any number of original or facsimile counterparts and each of such counterparts shall for all purposes be deemed
to be an original, and all such counterparts shall together constitute but one and the same instrument.

 

9.7 Effect of Headings. The
section headings herein are for convenience only and are not part of this Agreement and shall not affect the interpretation thereof.

 

9.8 Amendments. This Agreement
may be amended by the parties hereto without the consent of any Registered Holder (i) for the purpose of curing any ambiguity,
or curing, correcting or supplementing any mistake, including to conform the provisions of this Agreement to the description of
the terms of the Warrants and this Agreement set forth in the Prospectus, or any defective provision contained herein or adding
or changing any other provisions with respect to matters or questions arising under this Agreement as the parties may deem necessary
or desirable and that the parties deem shall not adversely affect the interest of the Registered Holders, and (ii) to provide for
the delivery of Alternative Issuance pursuant to Section 4.4. All other modifications or amendments, including any modification
or amendment to increase the Warrant Price or shorten the Exercise Period shall require the vote or written consent of the Registered
Holders of a majority of the number of the then outstanding Public Warrants and, solely with respect to any amendment to the terms
of the Private Placement Warrants, Working Capital Warrants or Post-IPO Warrants or any provision of this Agreement with respect
to the Private Placement Warrants, Working Capital Warrants or Post-IPO Warrants, a majority of the number of then outstanding
Private Placement Warrants, Working Capital Warrants or Post-IPO Warrants. Notwithstanding the foregoing, the Company may lower
the Warrant Price or extend the duration of the Exercise Period pursuant to Sections 3.1 and 3.2, respectively,
without the consent of the Registered Holders.

 

9.9 Severability. This Agreement
shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity
or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable
term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms
to such invalid or unenforceable provision as may be possible and be valid and enforceable.

 

[Signature Page Follows]

 

    16

     

    

 

IN WITNESS WHEREOF, the parties hereto have
caused this Agreement to be duly executed as of the date first above written.

 

	 	IG ACQUISITION CORP.
	 	 
	 	By:	 
	 	Name:	Christian Goode
	 	Title:	Chief Executive Officer
	 	 
	 	CONTINENTAL STOCK TRANSFER & TRUST COMPANY, as Warrant Agent
	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 

 

[Signature Page to Warrant Agreement]

 

    17

     

    

 

EXHIBIT A

 

Form of Warrant Certificate

 

[FACE]

 

Number

 

Warrants

 

THIS WARRANT SHALL BE VOID IF NOT EXERCISED
PRIOR TO

THE EXPIRATION OF THE EXERCISE PERIOD
PROVIDED FOR

IN THE WARRANT AGREEMENT DESCRIBED BELOW

 

IG ACQUISITION CORP.

Incorporated Under the Laws of the State of Delaware

 

CUSIP 449534 114

Warrant Certificate

 

This Warrant Certificate certifies that 
                  , or registered assigns, is the registered holder of warrant(s)
evidenced hereby (the “Warrants” and each, a “Warrant”) to purchase shares of Class A common
stock, $0.0001 par value per share (“Class A Common Stock”), of IG Acquisition Corp.,
a Delaware corporation (the “Company”). Each whole Warrant entitles the holder, upon exercise during
the period set forth in the Warrant Agreement referred to below, to receive from the Company that number of fully paid and non-assessable
shares of Class A Common Stock as set forth below, at the exercise price (the “Warrant Price”)
as determined pursuant to the Warrant Agreement, payable in lawful money (or through “cashless exercise”
as provided for in the Warrant Agreement) of the United States of America upon surrender of this Warrant Certificate and payment
of the Warrant Price at the office or agency of the Warrant Agent referred to below, subject to the conditions set forth herein
and in the Warrant Agreement. Defined terms used in this Warrant Certificate but not defined herein shall have the meanings given
to them in the Warrant Agreement.

 

Each whole Warrant is initially exercisable
for one fully paid and non-assessable share of Class A Common Stock. No fractional shares will be issued upon exercise of any Warrant.
If, upon the exercise of Warrants, a holder would be entitled to receive a fractional interest in a share of Class A Common Stock,
the Company will, upon exercise, round down to the nearest whole number the number of shares of Class A Common Stock to be issued
to the Warrant holder. The number of shares of Class A Common Stock issuable upon exercise of the Warrants is subject to adjustment
upon the occurrence of certain events set forth in the Warrant Agreement.

 

The initial Warrant Price per share of
Class A Common Stock for any Warrant is equal to $11.50 per share. The Warrant Price is subject to adjustment upon the occurrence
of certain events set forth in the Warrant Agreement.

 

Subject to the conditions set forth in
the Warrant Agreement, the Warrants may be exercised only during the Exercise Period and to the extent not exercised by the end
of such Exercise Period, such Warrants shall become void. The Warrants may be redeemed, subject to certain conditions, as set forth
in the Warrant Agreement.

 

Reference is hereby made to the further
provisions of this Warrant Certificate set forth on the reverse hereof and such further provisions shall for all purposes have
the same effect as though fully set forth at this place.

 

This Warrant Certificate shall not be valid
unless countersigned by the Warrant Agent, as such term is used in the Warrant Agreement.

 

This Warrant Certificate shall be governed
by and construed in accordance with the internal laws of the State of New York.

 

	 	IG ACQUISITION CORP.
	 	 	 
	 	By:	/s/ Christian Goode
	 	Name:	Christian Goode
	 	Title:	Chief Executive Officer 
	 	 	 
	 	CONTINENTAL STOCK TRANSFER & TRUST COMPANY, as Warrant Agent
	 	 	 
	 	By:	/s/
Margaret B. Lloyd 
	 	Name: 	Margaret B. Lloyd
	 	Title:	Vice President  

 

    18

     

    

 

[Form of Warrant Certificate]

 

[Reverse]

 

The Warrants evidenced by this Warrant
Certificate are part of a duly authorized issue of Warrants entitling the holder on exercise to receive shares of Class A Common
Stock and are issued or to be issued pursuant to a Warrant Agreement dated as of _____, 2020 (the “Warrant Agreement”),
duly executed and delivered by the Company to Continental Stock Transfer & Trust Company, a New York corporation, as warrant
agent (the “Warrant Agent”), which Warrant Agreement is hereby incorporated by reference
in and made a part of this instrument and is hereby referred to for a description of the rights, limitation of rights, obligations,
duties and immunities thereunder of the Warrant Agent, the Company and the holders (the words “holders”
or “holder” meaning the Registered Holders or Registered Holder, respectively) of the Warrants. A copy
of the Warrant Agreement may be obtained by the holder hereof upon written request to the Company. Defined terms used in this Warrant
Certificate but not defined herein shall have the meanings given to them in the Warrant Agreement.

 

Warrants may be exercised at any time during
the Exercise Period set forth in the Warrant Agreement. The holder of Warrants evidenced by this Warrant Certificate may exercise
them by surrendering this Warrant Certificate, with the form of election to purchase set forth hereon properly completed and executed,
together with payment of the Warrant Price as specified in the Warrant Agreement (or through “cashless exercise” as
provided for in the Warrant Agreement) at the principal corporate trust office of the Warrant Agent. In the event that upon any
exercise of Warrants evidenced hereby the number of Warrants exercised shall be less than the total number of Warrants evidenced
hereby, there shall be issued to the holder hereof or his, her or its assignee, a new Warrant Certificate evidencing the number
of Warrants not exercised.

 

Notwithstanding anything else in this Warrant
Certificate or the Warrant Agreement, no Warrant may be exercised unless at the time of exercise (i) a registration statement covering
the shares of Class A Common Stock to be issued upon exercise is effective under the Securities Act and (ii) a prospectus thereunder
relating to the shares of Class A Common Stock is current, except through “cashless exercise” as provided for in the
Warrant Agreement.

 

The Warrant Agreement provides that upon
the occurrence of certain events the number of shares of Class A Common Stock issuable upon exercise of the Warrants set forth
on the face hereof may, subject to certain conditions, be adjusted. If, upon exercise of a Warrant, the holder thereof would be
entitled to receive a fractional interest in a share of Class A Common Stock, the Company shall, upon exercise, round down to the
nearest whole number of shares of Class A Common Stock to be issued to the holder of the Warrant.

 

Warrant Certificates, when surrendered
at the principal corporate trust office of the Warrant Agent by the Registered Holder thereof in person or by legal representative
or attorney duly authorized in writing, may be exchanged, in the manner and subject to the limitations provided in the Warrant
Agreement, but without payment of any service charge, for another Warrant Certificate or Warrant Certificates of like tenor evidencing
in the aggregate a like number of Warrants.

 

Upon due presentation for registration
of transfer of this Warrant Certificate at the office of the Warrant Agent a new Warrant Certificate or Warrant Certificates of
like tenor and evidencing in the aggregate a like number of Warrants shall be issued to the transferee(s) in exchange for this
Warrant Certificate, subject to the limitations provided in the Warrant Agreement, without charge except for any tax or other governmental
charge imposed in connection therewith.

 

The Company and the Warrant Agent may deem
and treat the Registered Holder(s) hereof as the absolute owner(s) of this Warrant Certificate (notwithstanding any notation of
ownership or other writing hereon made by anyone), for the purpose of any exercise hereof, of any distribution to the holder(s)
hereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary.
Neither the Warrants nor this Warrant Certificate entitles any holder hereof to any rights of a stockholder of the Company.

 

Election to Purchase

 

(To Be Executed Upon Exercise of Warrant)

 

The undersigned hereby irrevocably elects
to exercise the right, represented by this Warrant Certificate, to receive _____ shares of Class A Common Stock and herewith tenders
payment for such shares of Class A Common Stock to the order of IG Acquisition Corp. (the “Company”)
in the amount of $_____________ in accordance with the terms hereof. The undersigned requests that a certificate for such shares
of Class A Common Stock be registered in the name of _____________, whose address is and that such shares of Class A Common Stock
be delivered to ______________ whose address is _______________. If said number of shares of Class A Common Stock is less than
all of the shares of Class A Common Stock purchasable hereunder, the undersigned requests that a new Warrant Certificate representing
the remaining balance of such shares of Class A Common Stock be registered in the name of ___________________, whose address is
_______________ and that such Warrant Certificate be delivered to _______________, whose address is _______________.

 

In the event that the Warrant has been
called for redemption by the Company pursuant to Section 6.1 of the Warrant Agreement and the Company has required
cashless exercise pursuant to Section 6.3 of the Warrant Agreement, the number of shares of Class A Common Stock
that this Warrant is exercisable for shall be determined in accordance with subsection 3.3.1(b) and Section
6.3 of the Warrant Agreement.

 

In the event that the Warrant is a Private
Placement Warrant or a Working Capital Warrant that is to be exercised on a “cashless” basis pursuant to subsection
3.3.1(c) of the Warrant Agreement, the number of shares of Class A Common Stock that this Warrant is exercisable for shall
be determined in accordance with subsection 3.3.1(c) of the Warrant Agreement.

 

In the event that the Warrant is to be
exercised on a “cashless” basis pursuant to Section 7.4 of the Warrant Agreement, the number of shares
of Class A Common Stock that this Warrant is exercisable for shall be determined in accordance with Section 7.4 of
the Warrant Agreement.

 

In the event that the Warrant may be exercised,
to the extent allowed by the Warrant Agreement, through cashless exercise (i) the number of shares of Class A Common Stock that
this Warrant is exercisable for would be determined in accordance with the relevant section of the Warrant Agreement which allows
for such cashless exercise and (ii) the holder hereof shall complete the following: The undersigned hereby irrevocably elects to
exercise the right, represented by this Warrant Certificate, through the cashless exercise provisions of the Warrant Agreement,
to receive shares of Class A Common Stock. If said number of shares of Class A Common Stock is less than all of the shares of Class
A Common Stock purchasable hereunder (after giving effect to the cashless exercise), the undersigned requests that a new Warrant
Certificate representing the remaining balance of such shares of Class A Common Stock be registered in the name of   
             , whose address is                 
        and that such Warrant Certificate be delivered to                
, whose address is                 .

 

[Signature Page Follows]

    19

     

    

 

	Date:                , 20	 
	 	(Signature)
	 	 
	 	 
	 	 
	 	 
	 	(Address)
	 	 
	 	 
	 	(Tax Identification Number)
	Signature Guaranteed:	 
	 	 
	 	 

 

THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR
INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE
MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15 UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED (OR ANY SUCCESSOR RULE)).

 

    20

     

    

 

EXHIBIT B

 

LEGEND

 

“THE SECURITIES REPRESENTED BY THIS
CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE
OFFERED, SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND ANY APPLICABLE
STATE SECURITIES LAWS OR AN EXEMPTION FROM REGISTRATION IS AVAILABLE. IN ADDITION, SUBJECT TO ANY ADDITIONAL LIMITATIONS ON TRANSFER
DESCRIBED IN THE LETTER AGREEMENT BY AND AMONG IG ACQUISITION CORP. (THE “COMPANY”), IG SPONSOR LLC AND THE OTHER PARTIES
THERETO, THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD OR TRANSFERRED PRIOR TO THE DATE THAT IS THIRTY (30) DAYS
AFTER THE DATE UPON WHICH THE COMPANY COMPLETES ITS INITIAL BUSINESS COMBINATION (AS DEFINED IN SECTION 3 OF THE WARRANT AGREEMENT
REFERRED TO HEREIN) EXCEPT TO A PERMITTED TRANSFEREE (AS DEFINED IN SECTION 2 OF THE WARRANT AGREEMENT) WHO AGREES IN WRITING WITH
THE COMPANY TO BE SUBJECT TO SUCH TRANSFER PROVISIONS.

 

SECURITIES EVIDENCED BY THIS CERTIFICATE
AND SHARES OF CLASS A COMMON STOCK OF THE COMPANY ISSUED UPON EXERCISE OF SUCH SECURITIES SHALL BE ENTITLED TO REGISTRATION RIGHTS
UNDER A REGISTRATION RIGHTS AGREEMENT TO BE EXECUTED BY THE COMPANY.”

 

 

22

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}]]